OBO_ID (LABEL):	CL_0000771 (eosinophil)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC2621211	12/2008	S39-PMC2621211	['the Mice Gestated on both diets developed features characteristic of an allergic phenotype including Airway hyper-reactivity, Lung lavage Eosinophilia, and increase Serum Ige concentrations [9].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 4, 'mice'), ('GO_0007565', 'female pregnancy', 9, 'gestated'), ('UBERON_0001005', 'respiratory airway', 101, 'airway'), ('UBERON_0002048', 'lung', 126, 'lung'), ('CL_0000771', 'eosinophil', 138, 'eosinophilia'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE')]
PMC2999828	3/2009	S175-PMC2999828	['in addition, total and specific Ige levels,[72,73] total Eosinophil counts,[74] incidence of Airway disease,[74] and positive results on skin prick tests [75] were also increased in children who were exposed to smoke either during Pregnancy or in early childhood.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 32, 'IgE'), ('CL_0000771', 'eosinophil', 57, 'eosinophil'), ('UBERON_0001005', 'respiratory airway', 93, 'airway'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC3156327	4/2011	S119-PMC3156327	['a high Folate diet in Pregnant Mice resulted in altered Gene methylation patterns and decreased transcriptional activity in the Lung Tissue of the progeny with increased Airways hyper reactivity, Airway Eosinophilia and Production Of Inflammatory Chemokines (hollingsworth et al.2008).']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 7, 'folate'), ('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 31, 'mice'), ('GO_0010258', 'NADH dehydrogenase complex (plastoquinone) assembly', 56, 'gene'), ('SO_0000704', 'gene', 56, 'gene'), ('UBERON_0002048', 'lung', 128, 'lung'), ('UBERON_0000479', 'tissue', 133, 'tissue'), ('UBERON_0001005', 'respiratory airway', 170, 'airways'), ('UBERON_0001005', 'respiratory airway', 196, 'airway'), ('CL_0000771', 'eosinophil', 203, 'eosinophilia'), ('GO_0009951', 'polarity specification of dorsal/ventral axis', 220, 'production of inflammatory chemokines')]
PMC3501517	11/2012	S193-PMC3501517	['specifically, tem identification of Extravascular Erythrocytes, Fibroblast count, collagen bundles, Perivascular Mast Cells, Eosinophil count, and intra-Alveolar debris were all lower 8 and 12 weeks after radiation injury in the Rats given supplemental Vitamin D. Neutrophil count was lower at 8 weeks and Macrophage count was lower at 12 weeks in supplemented Rats, as well.']	N/A	N/A	[('GO_0043265', 'ectoplasm', 36, 'extravascular'), ('CL_0000232', 'erythrocyte', 50, 'erythrocytes'), ('CL_0000057', 'fibroblast', 64, 'fibroblast'), ('UBERON_0014930', 'perivascular space', 100, 'perivascular'), ('CL_0000097', 'mast cell', 113, 'mast cells'), ('CL_0000771', 'eosinophil', 125, 'eosinophil'), ('UBERON_0003215', 'alveolus', 153, 'alveolar'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 229, 'rats'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CL_0000775', 'neutrophil', 264, 'Neutrophil'), ('CL_0000235', 'macrophage', 306, 'macrophage'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 361, 'rats')]
PMC3553086	1/2013	S59-PMC3553086	['none of the Cpg Sites analysed for the smaller selection of bamse samples (n\u200a=\u200a260) were differentially methylated between the groups but they showed overall similar degree of methylation as compared to the Adult bioair samples (table s1).10.1371/journal.pone.0053877.t001\n\ncaption (table-wrap): table 1\ncharacteristics of the bioair study population (n\u200a=\u200a171).mild Adult asthmasevere Adult asthmacopdp-valuen566748age (years)41.6±13.250.3±13.263.8±8.5<0.05gender (% males)44.643.375<0.05bmi (kg/m2)25.2±3.8128.7±5.327.4±5.31<0.05current smokers (n\u200a=\u200a14)1211<0.05former smokers (n\u200a=\u200a67)121837fev1(%pred)87.3±18.371.4±21.450.0±16.1<0.05fvc (%pred)104.6±16.187.5±20.6177.2±16.5<0.05blood Eosinophils (109/l)0.31±0.2720.37±0.3530.23±0.293nsrs2168891 cc/ct/tt (%)83.9/14.3/1.883.6/16.4/091.7/8.3/0nsrs2168890 cc/ct/tt (%)69.1/30.9/0171.4/28.6/0473.3/26.7/05nsrs2530547 cc/ct/tt (%)29.1/54.5/16.4140.9/45.5/13.6140.4/48.9/.10.61nsrs887020 aa/ag/gg (%)28.6/53.6/17.917.9/52.2/29.920.8/58.3/20.8ns\ncopd - chronic obstructive Pulmonary disease, bmi – body mass index, fev1– forced expiratory volume in 1 second, fvc – forced vital capacity.']	N/A	N/A	[('SO_0000036', 'matrix_attachment_site', 12, 'CpG sites'), ('UBERON_0007023', 'adult organism', 207, 'adult'), ('UBERON_0007023', 'adult organism', 366, 'Adult'), ('UBERON_0007023', 'adult organism', 385, 'Adult'), ('CL_0000771', 'eosinophil', 686, 'eosinophils'), ('UBERON_0002048', 'lung', 1018, 'Pulmonary')]
PMC3553086	1/2013	S191-PMC3553086	['briefly, whole Blood, Peripheral Blood Mononuclear Cells (pbmc), Cd4+T Cells, Cd8+T-Cells, Cd56+Nk Cells, Cd19+B Cells, cd14+Monocytes, Granulocytes, Neutrophils and Eosinophils were isolated.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('CL_0000111', 'peripheral neuron', 22, 'peripheral blood'), ('UBERON_0000178', 'blood', 33, 'blood'), ('CL_0000226', 'single nucleate cell', 39, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 39, 'mononuclear'), ('PR_000001204', 'C-C chemokine receptor type 8', 65, 'CD4'), ('CL_0000084', 'T cell', 69, 'T cells'), ('PR_000005170', 'CD37 molecule', 78, 'CD8'), ('CL_0000084', 'T cell', 82, 'T-cells'), ('PR_000001309', 'CD70 molecule', 91, 'CD56'), ('CL_0000623', 'natural killer cell', 96, 'NK cells'), ('GO_0005634', 'nucleus', 96, 'NK'), ('PR_000001309', 'CD70 molecule', 106, 'CD19'), ('CL_0000236', 'B cell', 111, 'B cells'), ('CL_0000576', 'monocyte', 125, 'monocytes'), ('CL_0000094', 'granulocyte', 136, 'granulocytes'), ('CL_0000775', 'neutrophil', 150, 'neutrophils'), ('CL_0000771', 'eosinophil', 166, 'eosinophils')]
PMC3553086	1/2013	S193-PMC3553086	['magnetic-Activated Cell sorting (macs, miltenyi biotech, germany) was used to obtain T Cells, B Cells, Monocytes, and Nk Cells from the pbmc:s and Neutrophils and Eosinophils from the Granulocyte containing pellet.']	N/A	N/A	[('CL_0000161', 'acid secreting cell', 9, 'activated cell'), ('CL_0000084', 'T cell', 85, 'T cells'), ('CL_0000236', 'B cell', 94, 'B cells'), ('CL_0000576', 'monocyte', 103, 'monocytes'), ('CL_0000623', 'natural killer cell', 118, 'NK cells'), ('GO_0005634', 'nucleus', 118, 'NK'), ('CL_0000775', 'neutrophil', 147, 'neutrophils'), ('CL_0000771', 'eosinophil', 163, 'eosinophils'), ('CL_0000094', 'granulocyte', 184, 'granulocyte')]
PMC3553086	1/2013	S194-PMC3553086	['cell purities were Controlled by fluorescence activated cell sorting (facs) and ranged from lowest 81.8±18.8% for Eosinophils to highest 97.8±1.7% for Neutrophils.']	N/A	N/A	[('GO_0065007', 'biological regulation', 19, 'controlled'), ('CL_0000771', 'eosinophil', 114, 'eosinophils'), ('CL_0000775', 'neutrophil', 151, 'neutrophils')]
PMC3691177	6/2013	S46-PMC3691177	['Serum total Ige (immunocap, phadia, uppsala, sweden), 25(Oh)D and Eosinophil count were determined on the day of the child’s assessment.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 12, 'IgE'), ('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('CL_0000771', 'eosinophil', 66, 'eosinophil')]
PMC3691177	6/2013	S72-PMC3691177	['atopy was assessed by skin test for 95 children (53%), acceptable ios data were available for 51 (28%), Ige level for 86 (48%), eno level for 62 (34%) and Eosinophil count for 80 (44%).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 104, 'IgE'), ('CL_0000771', 'eosinophil', 155, 'eosinophil')]
PMC3691177	6/2013	S101-PMC3691177	['effect of Prenatal Vitamin D supplementation on objective measures of allergic inflammation\ntotal Ige levels, eno and Eosinophil counts were available for 106/180 (59%), 62/180 (34%) and 80/180 (44%) of offspring.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 10, 'Prenatal'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 98, 'IgE'), ('CL_0000771', 'eosinophil', 118, 'eosinophil')]
PMC3691177	6/2013	S103-PMC3691177	['ln Ige (a; n\u200a=\u200a86), eno (b; n\u200a=\u200a62), and ln Eosinophil count (c; n\u200a=\u200a90).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 3, 'IgE'), ('CL_0000771', 'eosinophil', 44, 'eosinophil')]
PMC3763666	7/2012	S26-PMC3763666	['the Immunoregulatory abnormalities are characterized by impaired th1-th2 cytokines balance, with a prevalent activation of th2 cytokines, which results in increased Serum Immunoglobulin Ige and elevated total circulating Eosinophil count [8].']	N/A	N/A	[('GO_0002026', 'regulation of the force of heart contraction', 4, 'immunoregulatory'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('GO_0019814', 'immunoglobulin complex', 171, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 186, 'IgE'), ('CL_0000771', 'eosinophil', 221, 'eosinophil')]
PMC3773919	9/2013	S141-PMC3773919	['during active treatment, Serum Eosinophil Cationic protein (ecp) levels significantly decreased.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('CL_0000771', 'eosinophil', 31, 'eosinophil'), ('CHEBI_36916', 'cation', 42, 'cationic')]
PMC3773919	9/2013	S220-PMC3773919	['administration of Food containing heat-treated lgg inhibited the onset and development of atopic skin lesions, accompanied by smaller numbers of Mast Cells and Eosinophils in the affected skin sites [14,21].']	N/A	N/A	[('CHEBI_33290', 'food', 18, 'food'), ('CL_0000097', 'mast cell', 145, 'mast cells'), ('CL_0000771', 'eosinophil', 160, 'eosinophils')]
PMC4233040	11/2014	S58-PMC4233040	['in H&e-stained Lung sections, the number of Eosinophils per square millimeter in the Peribronchial and Perivascular Tissue was assessed using image pro plus software (media cybernetics).']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 3, 'H'), ('UBERON_0002048', 'lung', 15, 'lung'), ('CL_0000771', 'eosinophil', 44, 'eosinophils'), ('UBERON_0014683', 'parasymphisial tooth whorl', 85, 'peribronchial ...'), ('GO_0043204', 'perikaryon', 103, 'perivascular'), ('UBERON_0014930', 'perivascular space', 103, 'perivascular'), ('UBERON_0000479', 'tissue', 116, 'tissue')]
PMC4233040	11/2014	S69-PMC4233040	['the Tissue was sectioned at a thickness of 4–5\xa0μm, and stained with H&e Solution for analyzing the difference between Eosinophils [29].']	N/A	N/A	[('UBERON_0000479', 'tissue', 4, 'tissue'), ('CHEBI_51686', 'haematoxylin', 68, 'H'), ('CHEBI_75958', 'solution', 72, 'solution'), ('CL_0000771', 'eosinophil', 118, 'eosinophils')]
PMC4233040	11/2014	S117-PMC4233040	['most of the infiltrating Inflammatory Cells were Eosinophils.']	N/A	N/A	[('CL_0000902', 'induced T-regulatory cell', 25, 'inflammatory cells'), ('CL_0000771', 'eosinophil', 49, 'eosinophils')]
PMC4233040	11/2014	S118-PMC4233040	['Tissue sections from the ova-exposed iugr Rats exhibited more prominent Eosinophil infiltration compared with the ova-exposed control Rats.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rats'), ('CL_0000771', 'eosinophil', 72, 'eosinophil'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats')]
PMC4233040	11/2014	S122-PMC4233040	['there were relatively few Eosinophils infiltrations in the control (e) and iugr (f) Rats.']	N/A	N/A	[('CL_0000771', 'eosinophil', 26, 'eosinophils'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 84, 'rats')]
PMC4233040	11/2014	S124-PMC4233040	['the histogram (i) showed the number of infiltrated Eosinophil Cells in Peribronchiolar and Perivascular lesions.']	N/A	N/A	[('CL_0000771', 'eosinophil', 51, 'eosinophil cells'), ('UBERON_0001297', 'serosa of uterus', 71, 'peribronchiolar'), ('UBERON_0014930', 'perivascular space', 91, 'perivascular')]
PMC4251881	11/2014	S70-PMC4251881	['complement leads to Chemotaxis of Eosinophils to the site of the ag-Ab Complex on the bmz, where they Degranulate and damage the dermal-Epidermal junction and cause blisters [5].']	N/A	N/A	[('GO_0006935', 'chemotaxis', 20, 'chemotaxis'), ('CL_0000771', 'eosinophil', 34, 'eosinophils'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'Ab'), ('GO_0032991', 'protein-containing complex', 71, 'complex'), ('GO_0030324', 'lung development', 102, 'degranulate'), ('UBERON_0007376', 'outer epithelium', 136, 'epidermal')]
PMC4251881	11/2014	S105-PMC4251881	['histopathology will show Eosinophilic spongiosis, subepidermal blister, dermal infiltrate of Eosinophils, and Lymphocytes.']	N/A	N/A	[('CL_0000771', 'eosinophil', 25, 'eosinophilic'), ('CL_0000771', 'eosinophil', 93, 'eosinophils'), ('CL_0000542', 'lymphocyte', 110, 'lymphocytes')]
PMC4329404	10/2014	S7-PMC4329404	['introduction of Vitamin D into the diet at weaning resulted in a significant reduction in Serum Ige levels, reduced Pulmonary Eosinophilia and Peri-Bronchiolar collagen deposition.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 90, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 96, 'IgE'), ('UBERON_0002048', 'lung', 116, 'pulmonary'), ('CL_0000771', 'eosinophil', 126, 'eosinophilia'), ('UBERON_0001789', 'outer nuclear layer of retina', 143, 'peri'), ('UBERON_0002186', 'bronchiole', 148, 'bronchiolar')]
PMC4329404	10/2014	S74-PMC4329404	['Vitamin D supplementation after weaning reduces Pulmonary Eosinophilia\ninflammation was determined in Mice following 6\xa0weeks of Allergen exposure and Ingestion of either a normal or Vitamin D-deficient diet.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002048', 'lung', 48, 'pulmonary'), ('CL_0000771', 'eosinophil', 58, 'eosinophilia'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice'), ('CHEBI_50904', 'allergen', 128, 'allergen'), ('GO_0007631', 'feeding behavior', 150, 'ingestion'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4329404	10/2014	S77-PMC4329404	['Eosinophils in the Bal (fig.2a) and total numbers of Inflammatory Cells in both the Bal and Lung were unaffected by Vitamin D status (fig.2a,b).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0006378', 'strand of vibrissa hair', 19, 'BAL'), ('CL_0000902', 'induced T-regulatory cell', 53, 'inflammatory cells'), ('UBERON_0006378', 'strand of vibrissa hair', 84, 'BAL'), ('UBERON_0002048', 'lung', 92, 'lung'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4329404	10/2014	S81-PMC4329404	['at 6\xa0weeks of age, both total and Eosinophil numbers in the bal (a) and Lung (b) were counted.']	N/A	N/A	[('CL_0000771', 'eosinophil', 34, 'eosinophil'), ('UBERON_0002048', 'lung', 72, 'lung')]
PMC4329404	10/2014	S134-PMC4329404	['moreover, offspring from Vitamin D insufficient females exposed to hdm and Fed a Vitamin D-deficient diet had increased Pulmonary Eosinophilia, Th2 Cells and reduced Cd4+Il-10+Regulatory Cells.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007631', 'feeding behavior', 75, 'fed'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0002048', 'lung', 120, 'pulmonary'), ('CL_0000771', 'eosinophil', 130, 'eosinophilia'), ('CL_0000546', 'T-helper 2 cell', 144, 'Th2 cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 166, 'CD4'), ('PR_000001470', 'interleukin-28B', 170, 'IL-10'), ('CL_0000232', 'erythrocyte', 176, 'regulatory cells'), ('GO_0065007', 'biological regulation', 176, 'regulatory')]
PMC4329404	10/2014	S136-PMC4329404	['introduction of Vitamin D after in utero and early-Life deficiency lowered disease severity in hdm-exposed neonatal Mice by reducing Eosinophilic inflammation, Airway Remodelling and serum Ige levels.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0000104', 'life cycle', 51, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'mice'), ('CL_0000771', 'eosinophil', 133, 'eosinophilic'), ('GO_0003313', 'heart rudiment development', 160, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 160, 'airway'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 189, 'IgE')]
PMC4448820	5/2015	S1305-PMC4448820	['Leukocytosis is classified according to the component of wbcs that contribute to an increase in the total number of wbcs; types include increased Neutrophil count, Lymphocyte count, Monocyte count, Eosinophilic Granulocyte count, Basophilic Granulocyte count, or Blastocyte (immature) Cells.']	N/A	N/A	[('GO_0043062', 'extracellular structure organization', 0, 'Leukocytosis'), ('CL_0000775', 'neutrophil', 146, 'neutrophil'), ('CL_0000542', 'lymphocyte', 164, 'lymphocyte'), ('CL_0000576', 'monocyte', 182, 'monocyte'), ('CL_0000771', 'eosinophil', 198, 'eosinophilic granulocyte'), ('CL_0000767', 'basophil', 230, 'basophilic granulocyte'), ('CL_0000055', 'non-terminally differentiated cell', 263, 'blastocyte ... cells')]
PMC4530571	4/2015	S21-PMC4530571	['these patients are atopic; Serum Immunoglobulin e (Ige) is increased, Airway inflammation is Eosinophilic, and fraction of exhaled Nitric Oxide (Feno) is high [28].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 27, 'serum'), ('GO_0019814', 'immunoglobulin complex', 33, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 51, 'IgE'), ('UBERON_0001005', 'respiratory airway', 70, 'airway'), ('CL_0000771', 'eosinophil', 93, 'eosinophilic'), ('CHEBI_16480', 'nitric oxide', 131, 'nitric oxide'), ('CHEBI_32035', 'potassium hydroxide', 145, 'FeNO')]
PMC4739392	2/2016	S172-PMC4739392	['** p \u2009<\u20090.01,tp \u2009=\u20090.052\n\nPlasma ecp\nPlasma Eosinophilic Cationic protein concentrations did not differ between the intervention groups.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 26, 'Plasma'), ('UBERON_0001969', 'blood plasma', 37, 'Plasma'), ('CL_0000771', 'eosinophil', 44, 'eosinophilic'), ('CHEBI_36916', 'cation', 57, 'cationic')]
PMC4820961	3/2016	S214-PMC4820961	['cell counts\nthe following subtypes of White Blood Cells were counted in Blood samples: Neutrophils, Lymphocytes, Monocytes, Eosinophils and Basophils56.']	N/A	N/A	[('CL_0000738', 'leukocyte', 38, 'white blood cells'), ('UBERON_0000178', 'blood', 44, 'blood'), ('UBERON_0000178', 'blood', 72, 'blood'), ('CL_0000775', 'neutrophil', 87, 'neutrophils'), ('CL_0000542', 'lymphocyte', 100, 'lymphocytes'), ('CL_0000576', 'monocyte', 113, 'monocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('CL_0000767', 'basophil', 140, 'basophils56')]
PMC4820961	3/2016	S286-PMC4820961	['before analysis, the normalized methylation m values were corrected for sex, age, array row, 96-well plate (dummy coded), White Blood Cell percentages (Neutrophils, Monocytes and Eosinophils; assessed at sample collection), and the first ten pcs derived from the genotype data, with the lm function in r. all analyses that included Genome-wide Snp data were performed on the residuals derived after correcting for these covariates.']	N/A	N/A	[('CL_0000738', 'leukocyte', 122, 'white blood cell'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000775', 'neutrophil', 152, 'neutrophils'), ('CL_0000576', 'monocyte', 165, 'monocytes'), ('CL_0000771', 'eosinophil', 179, 'eosinophils'), ('SO_0001026', 'genome', 332, 'genome'), ('SO_0000694', 'SNP', 344, 'SNP')]
PMC4896250	4/2016	S184-PMC4896250	['a standard questionnaire regarding demographic data, history of atopic disease (asthma, allergic rhinitis, atopic dermatitis, urticaria) was filled out, total Ige and Eosinophil count were assesed for each patient.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 159, 'IgE'), ('CL_0000771', 'eosinophil', 167, 'eosinophil')]
PMC4896250	4/2016	S377-PMC4896250	['they are characterized by the presence of a number of Inflammatory Cells resulting from infiltration of Eosinophils, Th2 Cells, Mast Cells, and Macrophages.']	N/A	N/A	[('CL_0000902', 'induced T-regulatory cell', 54, 'inflammatory cells'), ('CL_0000771', 'eosinophil', 104, 'eosinophils'), ('CL_0000546', 'T-helper 2 cell', 117, 'Th2 cells'), ('CL_0000097', 'mast cell', 128, 'mast cells'), ('CL_0000235', 'macrophage', 144, 'macrophages')]
PMC4896250	4/2016	S385-PMC4896250	['immunoassays were performed using polyp Tissue homogenates and Sera to quantify the levels of Rantes, Tnf-Α, and Il-5, and with Sera to assess total Ige, Eosinophil Cationic protein (ecp) produced by them.']	N/A	N/A	[('UBERON_0000479', 'tissue', 40, 'tissue'), ('UBERON_0001977', 'blood serum', 63, 'sera'), ('PR_000013712', 'E3 SUMO-protein ligase RanBP2', 94, 'RANTES'), ('PR_000000134', 'tumor necrosis factor alpha', 102, 'TNF-α'), ('PR_000001470', 'interleukin-28B', 113, 'IL-5'), ('UBERON_0001977', 'blood serum', 128, 'sera'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 149, 'IgE'), ('CL_0000771', 'eosinophil', 154, 'eosinophil'), ('CHEBI_36916', 'cation', 165, 'cationic')]
PMC4896250	4/2016	S670-PMC4896250	['none of the patients had peripheral Eosinophilia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 36, 'eosinophilia')]
PMC4896250	4/2016	S806-PMC4896250	['all patients had Eosinophilia with the mean Eosinophil count of 4,083/mm3(1,006-9,420).']	N/A	N/A	[('CL_0000771', 'eosinophil', 17, 'eosinophilia'), ('CL_0000771', 'eosinophil', 44, 'eosinophil')]
PMC4896250	4/2016	S811-PMC4896250	['all patients had complete spontaneous resolution of symptoms in parallel with the normalization of Eosinophil count within few months after the presentation.']	N/A	N/A	[('CL_0000771', 'eosinophil', 99, 'eosinophil')]
PMC4896250	4/2016	S839-PMC4896250	['• age group 19-54 years mean age 29.7yrs\n• duration of urticaria 6 months to 80 months\n• associated conditions:\n–Eosinophilia - 5 patients\n–hypothyroidism - 4 patients\n–microcyctic hypochromic anemia - 2 patients\n–autologous Serum skin test +ve\n–11/24 Serum group\n–7/17 saline group\nurticaria activity score (uas) came down form average 35.74 to 7 at the end of 9 weeks.saline group did not show reduction in Uas.']	N/A	N/A	[('CL_0000771', 'eosinophil', 113, 'Eosinophilia'), ('UBERON_0001977', 'blood serum', 225, 'serum'), ('UBERON_0001977', 'blood serum', 252, 'serum'), ('UBERON_0003671', 'anterior cruciate ligament of knee joint', 409, 'UAS')]
PMC4896250	4/2016	S940-PMC4896250	['these Mice exhibited high levels of specific Ige and th2-linked cytokines (Il-4, Il-5 and Il-13), as well as inflammatory Responses (Mast Cell and Eosinophil infiltration, Goblet Cell hyperplasia) in the Gut.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 6, 'mice'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 45, 'IgE'), ('PR_000001470', 'interleukin-28B', 75, 'IL-4'), ('PR_000001470', 'interleukin-28B', 81, 'IL-5'), ('PR_000001470', 'interleukin-28B', 90, 'IL-13'), ('GO_0060033', 'anatomical structure regression', 122, 'responses'), ('CL_0000097', 'mast cell', 133, 'mast cell'), ('CL_0000771', 'eosinophil', 147, 'eosinophil'), ('CL_0000160', 'goblet cell', 172, 'goblet cell'), ('UBERON_0001555', 'digestive tract', 204, 'gut')]
PMC4896250	4/2016	S952-PMC4896250	['we performed spirometrys and Methacholine challenge tests while measuring total Eosinophil count, and Serum levels of total Ige and ecp in all children.']	N/A	N/A	[('CHEBI_6805', 'methacycline', 29, 'methacholine'), ('CL_0000771', 'eosinophil', 80, 'eosinophil'), ('UBERON_0001977', 'blood serum', 102, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 124, 'IgE')]
PMC4896250	4/2016	S1012-PMC4896250	['Lung function parameters and Nasal Eosinophil counts (%) were measured.']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'Lung'), ('UBERON_0000004', 'nose', 29, 'nasal'), ('CL_0000771', 'eosinophil', 35, 'eosinophil')]
PMC4896250	4/2016	S1024-PMC4896250	['to induce Autophagy in vitro, hl-60 cells and Primary Eosinophil Cells were treated with Interleukin (Il)-5; a549 cells and Primary Airway Epithelial Cells were treated with Il-1Β.']	N/A	N/A	[('GO_0006914', 'autophagy', 10, 'autophagy'), ('CL_0000001', 'primary cultured cell', 46, 'primary'), ('CL_0000771', 'eosinophil', 54, 'eosinophil cells'), ('PR_000001470', 'interleukin-28B', 89, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 102, 'IL)-5'), ('CL_0000001', 'primary cultured cell', 124, 'primary'), ('CL_0000069', 'branched duct epithelial cell', 132, 'airway epithelial cells'), ('UBERON_0003209', 'blood nerve barrier', 132, 'airway epithelial'), ('PR_000001383', 'interleukin-22', 174, 'IL-1β')]
PMC4896250	4/2016	S1026-PMC4896250	['in confocal microscopy, Autophagosomes were observed in the Eosinophils from Sputum Granulocytes and pbcs of sa patients.']	N/A	N/A	[('GO_0005776', 'autophagosome', 24, 'autophagosomes'), ('CL_0000771', 'eosinophil', 60, 'eosinophils'), ('UBERON_0007311', 'sputum', 77, 'sputum'), ('CL_0000094', 'granulocyte', 84, 'granulocytes')]
PMC4896250	4/2016	S1027-PMC4896250	['Il-5 induced Autophagy in hl-60 cells with increased Eosinophil Cationic protein Expression.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'IL-5'), ('GO_0006914', 'autophagy', 13, 'autophagy'), ('CL_0000771', 'eosinophil', 53, 'eosinophil'), ('CHEBI_36916', 'cation', 64, 'cationic'), ('GO_0010467', 'gene expression', 81, 'expression')]
PMC4896250	4/2016	S1028-PMC4896250	['when Il-5 was treated on primary Eosinophils of sa patients, Autophagy Expression increased which were not affected by Dexamethasone.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-5'), ('CL_0000771', 'eosinophil', 33, 'eosinophils'), ('GO_0006914', 'autophagy', 61, 'autophagy'), ('GO_0010467', 'gene expression', 71, 'expression'), ('CHEBI_41879', 'dexamethasone', 119, 'dexamethasone')]
PMC4896250	4/2016	S1031-PMC4896250	['Autophagy Expression in peripheral Eosinophils from sa patients were significantly higher than those from nc ( p =0.013).']	N/A	N/A	[('GO_0006367', 'transcription initiation from RNA polymerase II promoter', 0, 'Autophagy'), ('GO_0010467', 'gene expression', 10, 'expression'), ('CL_0000771', 'eosinophil', 35, 'eosinophils')]
PMC4896250	4/2016	S1038-PMC4896250	['number of Eosinophils in Nasal Lavage Fluid and induced Sputum Eosinophils were determined.']	N/A	N/A	[('CL_0000771', 'eosinophil', 10, 'eosinophils'), ('UBERON_0000006', 'islet of Langerhans', 25, 'nasal lavage'), ('UBERON_0006314', 'bodily fluid', 38, 'fluid'), ('UBERON_0007311', 'sputum', 56, 'sputum'), ('CL_0000771', 'eosinophil', 63, 'eosinophils')]
PMC4896250	4/2016	S1041-PMC4896250	['Eosinophils in Nasal lavage fluid and Sputum increased significantly after npt in ar+ahr+ and ar+ahr- patients (p<0.001).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0000004', 'nose', 15, 'nasal'), ('UBERON_0007311', 'sputum', 38, 'sputum')]
PMC4896250	4/2016	S1135-PMC4896250	['histologic findings showed that Epidermal and dermal thickness, and Eosinophilic and Mast Cell infiltration in the skin of af group.']	N/A	N/A	[('UBERON_0007376', 'outer epithelium', 32, 'epidermal'), ('CL_0000771', 'eosinophil', 68, 'eosinophilic ...'), ('CL_0000097', 'mast cell', 85, 'mast cell')]
PMC4896250	4/2016	S1191-PMC4896250	['in Trpv1 knockout and Bctc treated Mice, Nasal Eosinophil infiltration and Nasal Mucosal cytokines transcriptional activities were decreased, when compared ova-challenged wild-type Mice.']	N/A	N/A	[('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 3, 'TRPV1'), ('CHEBI_75508', '5-bromo-4-chloro-3-indolyl phosphate', 22, 'BCTC'), ('NCBITaxon_10088', 'Mus <genus>', 35, 'mice'), ('UBERON_0000004', 'nose', 41, 'nasal'), ('CL_0000771', 'eosinophil', 47, 'eosinophil'), ('UBERON_0001707', 'nasal cavity', 75, 'nasal mucosal'), ('NCBITaxon_10088', 'Mus <genus>', 181, 'mice')]
PMC4896250	4/2016	S1199-PMC4896250	['variables including age, sex, body mass index, parental allergic history, income, maternal education level, ar treatment during the last 12 months, environmental tobacco smoking exposure, total Serum Ige levels, Eosinophil percentage, diagnosis of atopic dermatitis and asthma, Lung function tests, bhr to Methacholine and skin prick tests were used in the latent class analysis.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 194, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 200, 'IgE'), ('CL_0000771', 'eosinophil', 212, 'eosinophil'), ('UBERON_0002048', 'lung', 278, 'lung'), ('CHEBI_6805', 'methacycline', 306, 'methacholine')]
PMC4896250	4/2016	S1202-PMC4896250	['total Serum Ige levels and Serum Eosinophil percentages were highest in cluster 3.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 6, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 12, 'IgE'), ('UBERON_0001977', 'blood serum', 27, 'serum'), ('CL_0000771', 'eosinophil', 33, 'eosinophil')]
PMC4896250	4/2016	S1335-PMC4896250	['in hss/dress, 38 (73.1%) had fever over 38.5 °c, 17 (32.7%) had Eosinophilia with a median 1.71 g/l.']	N/A	N/A	[('CL_0000771', 'eosinophil', 64, 'eosinophilia')]
PMC4896250	4/2016	S1500-PMC4896250	['results: intravenous injection of T-Mscs significantly reduced allergic symptoms, Eosinophil, Neutrophil, Nasal polyp count and Serum ova specific-Igg1 levels.']	N/A	N/A	[('CL_0000084', 'T cell', 34, 'T-MSCs'), ('CL_0000771', 'eosinophil', 82, 'eosinophil'), ('CL_0000775', 'neutrophil', 94, 'neutrophil'), ('UBERON_0000004', 'nose', 106, 'nasal'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 147, 'IgG1')]
PMC4896250	4/2016	S1589-PMC4896250	['omalizumab did not alter Eosinophilia or markers of inflammation.']	N/A	N/A	[('CL_0000771', 'eosinophil', 25, 'eosinophilia')]
PMC4896250	4/2016	S1593-PMC4896250	['omalizumab did not reduce markers of Eosinophilic inflammation, nor Neutrophilic inflammation in Nasal secretions.']	N/A	N/A	[('CL_0000771', 'eosinophil', 37, 'eosinophilic'), ('CL_0000775', 'neutrophil', 68, 'neutrophilic'), ('UBERON_0000004', 'nose', 97, 'nasal')]
PMC4896250	4/2016	S1603-PMC4896250	['Airway infiltration of Eosinophils and Lymphocytes of Mice transferred with ss clones were effectively inhibited by the administration of Dex.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 0, 'Airway'), ('CL_0000771', 'eosinophil', 23, 'eosinophils'), ('CL_0000542', 'lymphocyte', 39, 'lymphocytes'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'mice'), ('CHEBI_4450', 'desmopressin', 138, 'DEX')]
PMC4896250	4/2016	S1605-PMC4896250	['administration of Ctla4-ig significantly suppressed the Proliferation of Dex-treated sr clones in vitro , and the Eosinophil infiltration of sr asthma model transferred with sr clones in vivo .']	N/A	N/A	[('PR_000006021', 'chymotrypsin-like protease CTRL-1', 18, 'CTLA4'), ('GO_0008283', 'cell proliferation', 56, 'proliferation'), ('CHEBI_4450', 'desmopressin', 73, 'DEX'), ('CL_0000771', 'eosinophil', 114, 'eosinophil')]
PMC4896250	4/2016	S1772-PMC4896250	['asthma control questionnaire (acq), Blood Eosinophils were assessed at the same time.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('CL_0000771', 'eosinophil', 42, 'eosinophils')]
PMC4896250	4/2016	S1779-PMC4896250	['a125 atp, a danger signal, activates Human Eosinophils via p2 Purinergic receptors\n\ntakehito kobayashi1, tooru noguchi1, tomoyuki soma1, kazuyuki nakagome1, hidetomo nakamoto1, hirohito kita2, makoto nagata1\n\n1saitama medical university, japan;2mayo clinic college of medicine, usa\n\ncorrespondence: takehito kobayashi – saitama medical university, japan\nbackground: Eosinophils recognize various stimuli resulting in their accumulation in Mucosal Tissues and the progression of inflammation.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 37, 'human'), ('CL_0000771', 'eosinophil', 43, 'eosinophils'), ('CHEBI_35330', 'spheroidene', 62, 'purinergic'), ('CL_0000771', 'eosinophil', 366, 'Eosinophils'), ('UBERON_0000344', 'mucosa', 439, 'mucosal'), ('UBERON_0000479', 'tissue', 447, 'tissues')]
PMC4896250	4/2016	S1783-PMC4896250	['methods: Eosinophils isolated from Peripheral Blood of normal Individuals were incubated in the presence or absence of monosodium Urate (msu) crystals and Atpγs, a non-hydrolysable atp analogue.']	N/A	N/A	[('CL_0000771', 'eosinophil', 9, 'Eosinophils'), ('UBERON_0012101', 'perinatal stage', 35, 'peripheral'), ('UBERON_0000178', 'blood', 46, 'blood'), ('NCBITaxon_1', 'root', 62, 'individuals'), ('CHEBI_46819', 'urate salt', 130, 'urate'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 155, 'ATPγS')]
PMC4896250	4/2016	S1784-PMC4896250	['to determine the involvement of P2 or P2Y2Receptors in Eosinophil responses to ua and atp, Eosinophils were preincubated with a pan-P2 Receptor Inhibitor, oxidized atp (oatp), or anti-P2Y2Antibody before incubation with msu crystals or Atpγs.']	N/A	N/A	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 32, 'P2'), ('PR_000001659', 'prostaglandin E2 receptor EP3 subtype', 38, 'P2Y2receptors'), ('CL_0000771', 'eosinophil', 55, 'eosinophil'), ('CL_0000771', 'eosinophil', 91, 'eosinophils'), ('PR_000001659', 'prostaglandin E2 receptor EP3 subtype', 132, 'P2 receptor'), ('CHEBI_35222', 'inhibitor', 144, 'inhibitor'), ('PR_000001909', 'platelet glycoprotein V', 184, 'P2Y2antibody'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 236, 'ATPγS')]
PMC4896250	4/2016	S1785-PMC4896250	['results: msu crystals induced adhesion of Eosinophils to recombinant Human (rh)-Icam-1 and induced Production Of Superoxide Anion.']	N/A	N/A	[('CL_0000771', 'eosinophil', 42, 'eosinophils'), ('NCBITaxon_9606', 'Homo sapiens', 69, 'human'), ('GO_0031012', 'extracellular matrix', 80, 'ICAM'), ('PR_000001367', 'interleukin-12 receptor subunit beta-1', 80, 'ICAM-1'), ('GO_0019688', 'purine deoxyribonucleoside interconversion', 99, 'production of superoxide anion'), ('CHEBI_62945', 'thromboxane anion', 113, 'superoxide anion')]
PMC4896250	4/2016	S1788-PMC4896250	['oatp and anti-P2Y2Significantly reduced these Eosinophil responses.']	N/A	N/A	[('PR_000001909', 'platelet glycoprotein V', 14, 'P2Y2significantly'), ('CL_0000771', 'eosinophil', 46, 'eosinophil')]
PMC4896250	4/2016	S1789-PMC4896250	['conclusions: ua stimulated Eosinophils to release atp.']	N/A	N/A	[('CL_0000771', 'eosinophil', 27, 'eosinophils')]
PMC4896250	4/2016	S1899-PMC4896250	['Eosinophils from Peripheral Blood were extracted then stimulated with both Fungi.']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophils'), ('UBERON_0012101', 'perinatal stage', 17, 'peripheral'), ('UBERON_0000178', 'blood', 28, 'blood'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'fungi')]
PMC4896250	4/2016	S1900-PMC4896250	['Nasal Fibroblasts were co-cultured with Activated Eosinophils with or without physical contact for 24 hours.']	N/A	N/A	[('UBERON_0000025', 'tube', 0, 'Nasal'), ('CL_0000057', 'fibroblast', 6, 'fibroblasts'), ('CL_0002627', 'mature astrocyte', 40, 'activated'), ('CL_0000771', 'eosinophil', 50, 'eosinophils')]
PMC4896250	4/2016	S1904-PMC4896250	['co-culture of Activated Eosinophils with Fungi and Nasal Fibroblasts enhanced Extracellular Matrix mrna Expression 1.8 to 2.6 times than co-cultured with non-activated Eosinophil group.']	N/A	N/A	[('CL_0002627', 'mature astrocyte', 14, 'activated'), ('CL_0000771', 'eosinophil', 24, 'eosinophils'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'fungi'), ('CL_0002480', 'nasal mucosa goblet cell', 51, 'nasal fibroblasts'), ('UBERON_0000004', 'nose', 51, 'nasal'), ('GO_0031012', 'extracellular matrix', 78, 'extracellular matrix'), ('GO_0010467', 'gene expression', 104, 'expression'), ('CL_0000771', 'eosinophil', 168, 'eosinophil')]
PMC4896250	4/2016	S2054-PMC4896250	['Tslp treatment reduced total cell counts and Eosinophil counts in Bal Fluid and Ahr to Methacholine.']	N/A	N/A	[('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 0, 'TSLP'), ('CL_0000771', 'eosinophil', 45, 'eosinophil'), ('UBERON_0006310', 'vitelline venous plexus', 66, 'BAL fluid'), ('UBERON_0009746', 'head fold of embryonic disc', 80, 'AHR'), ('CHEBI_6805', 'methacycline', 87, 'methacholine')]
PMC4896250	4/2016	S2061-PMC4896250	['we measured Nasal volume change and symptom change before and after the Aspirin Nasal provocation test (anpt), and examined patient’s asthma history, allergy, lund-mackay score (lms), total Immunoglobulin e, peripheral Eosinophil percentage, and objective measurement relapse.']	N/A	N/A	[('UBERON_0000004', 'nose', 12, 'nasal'), ('CHEBI_2904', 'atenolol', 72, 'aspirin'), ('UBERON_0000004', 'nose', 80, 'nasal'), ('GO_0019814', 'immunoglobulin complex', 190, 'immunoglobulin'), ('CL_0000771', 'eosinophil', 219, 'eosinophil')]
PMC4896250	4/2016	S2087-PMC4896250	['a148 discrimination between non-Eosinophilic and eosinophilic chronic rhinosinusitis with Nasal polyps\n\npona park1, hong ryul jin1, dong-kyu kim2, dae woo kim1\n\n1boramae medical center, south korea;2chuncheon sacred Heart hospital\n\ncorrespondence: pona park – boramae medical center, south korea\nbackground: chronic rhinosinusitis with Nasal polyps (crswnp) is classified as Eosinophilic or non-Eosinophilic crswnp depending on histopathological features.']	N/A	N/A	[('CL_0000771', 'eosinophil', 32, 'eosinophilic'), ('UBERON_0000004', 'nose', 90, 'nasal'), ('UBERON_0000948', 'heart', 216, 'Heart'), ('UBERON_0000004', 'nose', 336, 'nasal'), ('CL_0000771', 'eosinophil', 375, 'eosinophilic'), ('CL_0000771', 'eosinophil', 395, 'eosinophilic')]
PMC4896250	4/2016	S2096-PMC4896250	['in non-Eosinophilic nps, ki-67 Expression was upregulated, especially in Epithelia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 7, 'eosinophilic'), ('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0000483', 'epithelium', 73, 'epithelia')]
PMC4896250	4/2016	S2098-PMC4896250	['a criterion combining the cutoff level (2,167) of Ethmoidal/Maxillary ct scores and the presence of Pseudocysts on endoscopic examination yielded a sensitivity of 100.0% and a specificity of 71.0% for the diagnosis of non-Eosinophilic crswnp.']	N/A	N/A	[('UBERON_0001679', 'ethmoid bone', 50, 'ethmoidal'), ('UBERON_0002397', 'maxilla', 60, 'maxillary'), ('GO_0044157', 'host cell projection', 100, 'pseudocysts'), ('CL_0000771', 'eosinophil', 222, 'eosinophilic')]
PMC4896250	4/2016	S2108-PMC4896250	['total cells numbers, and percentages of Eosinophils and Lymphocytes in the Bronchoalveolar Lavage Fluid as markers for Allergic inflammation were significantly decreased in the offspring of dams Fed scgos/lcfos during Lactation.']	N/A	N/A	[('CL_0000771', 'eosinophil', 40, 'eosinophils'), ('CL_0000542', 'lymphocyte', 56, 'lymphocytes'), ('UBERON_0004212', 'glomerular capillary', 75, 'bronchoalveolar lavage fluid'), ('GO_0040011', 'locomotion', 119, 'allergic'), ('GO_0007631', 'feeding behavior', 195, 'fed'), ('GO_0007595', 'lactation', 218, 'lactation')]
PMC4896250	4/2016	S2130-PMC4896250	['a151 clinical significance between the allergic test and Serum Eosinophil Cationic protein\n\nboo-young kim, soo whan kim\n\ncollege of medicine, the catholic university of korea, south korea\n\ncorrespondence: boo-young kim – college of medicine, the catholic university of korea, south korea\nintroduction: the Eosinophil Cationic protein (ecp) is a small polypeptide that originates from Activated Eosinophil Granulocytes.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 57, 'serum'), ('CL_0000771', 'eosinophil', 63, 'eosinophil'), ('CHEBI_36916', 'cation', 74, 'cationic'), ('CL_0000771', 'eosinophil', 306, 'eosinophil'), ('CHEBI_36916', 'cation', 317, 'cationic'), ('CL_0002627', 'mature astrocyte', 384, 'activated'), ('CL_0000771', 'eosinophil', 394, 'eosinophil granulocytes')]
PMC4896250	4/2016	S2135-PMC4896250	['we tested the Serum ecp, total Ig e, Eosinophil counts, datas of skin test, datas of mast in all patients.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 14, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 31, 'Ig'), ('CL_0000771', 'eosinophil', 37, 'eosinophil')]
PMC4896250	4/2016	S2184-PMC4896250	['in addition, there was no significant difference in levels of Peripheral Blood Eosinophil percentage and total Ige.']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 62, 'peripheral blood'), ('CL_0000771', 'eosinophil', 79, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 111, 'IgE')]
PMC4896250	4/2016	S2204-PMC4896250	['laboratory findings showed hemoglobin level 16.6 mg/dl, Platelet count 265,000/mm3, wbc counts 6300/mm3 with differential 16.7% of Eosinophils on corrected Blood chemistry.']	N/A	N/A	[('CL_0000233', 'platelet', 56, 'platelet'), ('CL_0000771', 'eosinophil', 131, 'eosinophils'), ('UBERON_0000178', 'blood', 156, 'blood')]
PMC4896250	4/2016	S2207-PMC4896250	['there is no evidence of Eosinophilic infiltration on Lung and Heart in Chest x-ray, Pulmonary function test and echocardiogram.']	N/A	N/A	[('CL_0000771', 'eosinophil', 24, 'eosinophilic'), ('UBERON_0002048', 'lung', 53, 'lung'), ('UBERON_0000948', 'heart', 62, 'heart'), ('UBERON_0001443', 'chest', 71, 'chest'), ('UBERON_0002048', 'lung', 84, 'pulmonary')]
PMC4896250	4/2016	S2209-PMC4896250	['pathologic findings represented Eosinophilic infiltration of entire Bowel layers.']	N/A	N/A	[('CL_0000771', 'eosinophil', 32, 'eosinophilic'), ('UBERON_0000160', 'intestine', 68, 'bowel')]
PMC4896250	4/2016	S2210-PMC4896250	['patient’s symptoms were relieved after surgery and followed Blood chemistry showed improvement of peripheral Eosinophilia 16.7% to 3.5%.']	N/A	N/A	[('UBERON_0000178', 'blood', 60, 'blood'), ('CL_0000771', 'eosinophil', 109, 'eosinophilia')]
PMC4896250	4/2016	S2211-PMC4896250	['conclusion\neosinophilic gastroenteritis is diagnosed by Eosinophilic infiltration of Gastrointestinal Tract without other causes of eosinophilia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 56, 'eosinophilic'), ('UBERON_0001555', 'digestive tract', 85, 'gastrointestinal tract')]
PMC4896250	4/2016	S2231-PMC4896250	['a158 a case of Eosinophilic granulomatosis with polyangiitis accompanied by rapidly progressive glomerulonephritis\n\nyu jin kim1, sang min lee1, shin myung kang1, sojeong kim1, sun young kyung1, sung hwan jeong1, jeong-woong park1, hyunjung hwang1, yong han seon1, sanghui park2, sang pyo lee1\n\n1gachon university gil medical center, incheon, south korea;2ewha womans university school of medicine, seoul, south korea\n\ncorrespondence: yu jin kim – gachon university gil medical center, incheon, south korea\na 58-year-old man visited local clinic complaining of malaise, weight loss, fever, and dyspnea.']	N/A	N/A	[('CL_0000771', 'eosinophil', 15, 'eosinophilic')]
PMC4896250	4/2016	S2232-PMC4896250	['complete Blood count was performed, which revealed Eosinophilia in peripheral Blood.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000771', 'eosinophil', 51, 'eosinophilia'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC4896250	4/2016	S2236-PMC4896250	['Kidney biopsy and skin biopsy were performed, and histological examination showed acute necrotizing crescentic glomerulonephritis and leukoclastic vasculitis in skin, which led to the diagnosis of churg-strauss syndrome (Eosinophilic granulomatosis with polyangiitis, egpa) combined with rapidly progressive glomerulonephritis (rpgn).']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Kidney'), ('CL_0000771', 'eosinophil', 221, 'eosinophilic')]
PMC4896250	4/2016	S2364-PMC4896250	['Blood tests on admission showed hemoglobin 16.1 g/dl, total Leukocyte count 5265 /ul (Neutrophils 78.7%, Lymphocytes 11.2%, Eosinophils 4.9%), ast 47 iu/l, alt 49 iu/l, Serum Bilirubin 0.55 mg/dl, serum creatinine 0.91 mg/dl and Blood Glucose 95 mg/dl.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000738', 'leukocyte', 60, 'leukocyte'), ('CL_0000775', 'neutrophil', 86, 'neutrophils'), ('CL_0000542', 'lymphocyte', 105, 'lymphocytes'), ('CL_0000771', 'eosinophil', 124, 'eosinophils'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_16990', 'bilirubin IXalpha', 175, 'bilirubin'), ('UBERON_0000178', 'blood', 229, 'blood'), ('CHEBI_17234', 'glucose', 235, 'glucose')]
PMC4896250	4/2016	S2413-PMC4896250	['cross-sectional data (Serum total Ige, Blood Eosinophil, fev1, bronchodilator response, pc20, asthma severity), and longitudinal data (number of exacerbations, mean ics dose, fev1 variability) were compared by the presence of Fungal sensitization, defined as positive (a/h > 1 or mean Wheal diameter greater than 3mm) skin prick test to Fungal Allergen ( aspergillus, alternaria, cladosporium, Epicoccum, fusarium, penicilliium, trichopyton ).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 34, 'IgE'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CL_0000771', 'eosinophil', 45, 'eosinophil'), ('NCBITaxon_10088', 'Mus <genus>', 226, 'fungal'), ('UBERON_0001688', 'incus bone', 285, 'wheal'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'fungal'), ('CHEBI_50904', 'allergen', 344, 'allergen'), ('NCBITaxon_10088', 'Mus <genus>', 394, 'Epicoccum')]
PMC4896250	4/2016	S2556-PMC4896250	['Eosinophilia was defined when the absolute Eosinophil count exceeds 500/μl in the Peripheral Blood.']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilia'), ('CL_0000771', 'eosinophil', 43, 'eosinophil'), ('UBERON_0012101', 'perinatal stage', 82, 'peripheral blood')]
PMC4896250	4/2016	S2558-PMC4896250	['results: the cumulative prevalence of Eosinophilia was 4.0% (1,963 out of 48,858).']	N/A	N/A	[('CL_0000771', 'eosinophil', 38, 'eosinophilia')]
PMC4896250	4/2016	S2560-PMC4896250	['Eosinophilic subjects were older and more male-predominant ( p<0.001, respectively).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilic')]
PMC4896250	4/2016	S2563-PMC4896250	['Eosinophilic subjects showed higher positive rate for common parasite elisa ( p<0.001).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilic')]
PMC4896250	4/2016	S2565-PMC4896250	['conclusions: Eosinophilia in general, healthy population was not uncommon and usually in mild degree.']	N/A	N/A	[('CL_0000771', 'eosinophil', 13, 'Eosinophilia')]
PMC4896250	4/2016	S2567-PMC4896250	['a180 the prevalence of toxocariasis and diagnostic value of serologic tests in asymptomatic korean Adults\n\njin-young lee1, kyoung won ha2, yun-jin jeung3, sehyo yune4, byung-jae lee4, dong-chull choi5, mi-jung oh6, young hee lim7\n\n1health promotion center, samsung medical center, south korea;2seoul samsung medical clinic;3clean medicine allergy clinic;4samsung medical center;5samsung medical center, sungkyunkwan university school of medicine;6bundang jesaeng hospital;7ansan sarang general hospital\n\ncorrespondence: jin-young lee – health promotion center, samsung medical center, south korea\npurpose: toxocariasis is the most common cause of peripheral Blood Eosinophilia in korea and produces Eosinophilic infiltration into various Organs, including the Lung.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 99, 'adults'), ('UBERON_0000178', 'blood', 658, 'blood'), ('CL_0000771', 'eosinophil', 664, 'eosinophilia'), ('CL_0000771', 'eosinophil', 699, 'eosinophilic'), ('UBERON_0000062', 'organ', 738, 'organs'), ('UBERON_0002048', 'lung', 760, 'lung')]
PMC4896250	4/2016	S2656-PMC4896250	['Antagomir treatment reduced total cell counts and Eosinophil counts in Bal Fluid.']	N/A	N/A	[('CHEBI_2704', 'anastrozole', 0, 'Antagomir'), ('CL_0000771', 'eosinophil', 50, 'eosinophil'), ('UBERON_0006310', 'vitelline venous plexus', 71, 'BAL fluid')]
PMC4896250	4/2016	S2717-PMC4896250	['characteristics of asthma sub-phenotypes were analyzed by disease severity, Pulmonary function, Blood Eosinophil counts, total Ige levels in Serum, and specific Ige Antibody to environmental Allergens.']	N/A	N/A	[('UBERON_0002048', 'lung', 76, 'pulmonary'), ('UBERON_0000178', 'blood', 96, 'blood'), ('CL_0000771', 'eosinophil', 102, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 127, 'IgE'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 161, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody'), ('CHEBI_33663', 'cyclic hydrocarbon', 191, 'allergens')]
PMC4896250	4/2016	S2719-PMC4896250	['there were no significant differences in the distribution of severity, fev1 percent predicted, Blood Eosinophil counts and total Ige levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood'), ('CL_0000771', 'eosinophil', 101, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 129, 'IgE')]
PMC4896250	4/2016	S2741-PMC4896250	['a192 discordance between Sputum eosinophilia and exhaled Nitric Oxide\n\njin-young lee1, byung-jae lee2, dong-chull choi2, jae-won paeng3, mi-jin jang3, jihye kim4, young nam kim4, sehyo yune4\n\n1health promotion center, samsung medical center;2samsung medical center, sungkyunkwan university school of medicine;3samsung biomedical research institute;4samsung medical center, south korea\n\ncorrespondence: sehyo yune – samsung medical center, south korea\nbackground: fractional exhaled Nitric Oxide (Feno) and induced Sputum Eosinophil count (ise) are noninvasive methods to assess Airway inflammation in patients with asthma.']	N/A	N/A	[('UBERON_0007311', 'sputum', 25, 'sputum'), ('CHEBI_16480', 'nitric oxide', 57, 'nitric oxide'), ('CHEBI_16480', 'nitric oxide', 482, 'nitric oxide'), ('CHEBI_32035', 'potassium hydroxide', 496, 'FeNO'), ('UBERON_0007311', 'sputum', 514, 'sputum'), ('CL_0000771', 'eosinophil', 521, 'eosinophil'), ('UBERON_0001005', 'respiratory airway', 578, 'airway')]
PMC4896250	4/2016	S2746-PMC4896250	['the cutoff value differentiating high and low ise was 3% of Eosinophils in induced Sputum.']	N/A	N/A	[('CL_0000771', 'eosinophil', 60, 'eosinophils'), ('UBERON_0007311', 'sputum', 83, 'sputum')]
PMC4896250	4/2016	S2785-PMC4896250	['Ige level (232.9; 95% ci, 179.4-302.4 vs. 68.43; 95% ci, 62.51-74.91, p=<.0001) and Eosinophil fraction (4.65; 95% ci, 3.96-5.46 vs. 2.86; 95% ci, 2.72-3.01, p=<.0001) of atopic current ar were higher than non- atopic current ar group.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 0, 'IgE'), ('CL_0000771', 'eosinophil', 84, 'eosinophil')]
PMC4896250	4/2016	S2939-PMC4896250	['Hur ko Mice had significant decreases in Lung Neutrophils, Lymphocytes, Eosinophils and Il-13.']	N/A	N/A	[('PR_000008840', 'huntingtin', 0, 'HuR'), ('NCBITaxon_10088', 'Mus <genus>', 7, 'mice'), ('UBERON_0002048', 'lung', 41, 'lung'), ('CL_0000775', 'neutrophil', 46, 'neutrophils'), ('CL_0000542', 'lymphocyte', 59, 'lymphocytes'), ('CL_0000771', 'eosinophil', 72, 'eosinophils'), ('PR_000001470', 'interleukin-28B', 88, 'IL-13')]
PMC4896250	4/2016	S3183-PMC4896250	['there were significantly difference in severe asthma (27.3%, 14.8%, 19.7% and 7.7% in cluster 1, 2, 3 and 4, respectively, p =0.042), total Ige (564.3±732.5, 216.5±266.4, 352.0±398.7 and 345.5±440.7, p<0.001), Sputum Eosinophil (%)(31.5±37.8, 29.4±39.7, 13.4±27.3 and 18.7±30.9, p =0.024), and peripheral Eosinophil count (485.0±374.8, 523.0±561.4, 349.3±379.3 and 245.1±242.5, p<0.001).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 140, 'IgE'), ('UBERON_0007311', 'sputum', 210, 'sputum'), ('CL_0000771', 'eosinophil', 217, 'eosinophil'), ('CL_0000771', 'eosinophil', 305, 'eosinophil')]
PMC4896250	4/2016	S3275-PMC4896250	['results: Intralymphatic injection by ova-Flab Mixture reduced symptom score, Eosinophil infiltration in the Nasal Mucosa and total and ova-specific Ige levels more significantly than intranasal and sublingual administration.']	N/A	N/A	[('UBERON_0001837', 'duct of salivary gland', 9, 'Intralymphatic'), ('PR_000007593', 'glutamate carboxypeptidase 2', 41, 'FlaB'), ('CHEBI_60004', 'mixture', 46, 'mixture'), ('CL_0000771', 'eosinophil', 77, 'eosinophil'), ('UBERON_0000331', 'ileal mucosa', 108, 'nasal mucosa'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 148, 'IgE')]
PMC4896250	4/2016	S3309-PMC4896250	['the number of total cells, Macrophages and Eosinophils in Bal Fluid was decreased in nrf2 -/- compared with nrf2 +/+ Mice, this was also the case for the ahr changes in both of balb/c and c57bl/6 Mice.']	N/A	N/A	[('CL_0000235', 'macrophage', 27, 'macrophages'), ('CL_0000771', 'eosinophil', 43, 'eosinophils'), ('UBERON_0006310', 'vitelline venous plexus', 58, 'BAL fluid'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 196, 'mice')]
PMC4896250	4/2016	S3331-PMC4896250	['intravenous injection of T-Msc significantly reduced allergic symptoms, Eosinophil infiltration, Serum total and ova specific-Ige and the Nasal and systemic th2 cytokine profile.']	N/A	N/A	[('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 25, 'T'), ('CL_0000186', 'myofibroblast cell', 27, 'MSC'), ('CL_0000771', 'eosinophil', 72, 'eosinophil'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 126, 'IgE'), ('UBERON_0000004', 'nose', 138, 'nasal')]
PMC4896250	4/2016	S3379-PMC4896250	['Budesonide reduced the number of Lymphocytes and Eosinophils in the bal.']	N/A	N/A	[('CHEBI_3220', 'Bupropion hydrochloride', 0, 'Budesonide'), ('CL_0000542', 'lymphocyte', 33, 'lymphocytes'), ('CL_0000771', 'eosinophil', 49, 'eosinophils')]
PMC4896250	4/2016	S3380-PMC4896250	['feeding gos in absence of Budesonide treatment reduced the number of Eosinophils as well.']	N/A	N/A	[('CHEBI_3219', 'bupropion', 26, 'budesonide'), ('CL_0000771', 'eosinophil', 69, 'eosinophils')]
PMC4896250	4/2016	S3537-PMC4896250	['all patients were measured Serum total Eosinophil count, total Ige, Allergen-specific Ige against house dust Mite(dp, df), alternaria, cat dander, Cockroach, Tree mixes by the immunocap or skin prick test.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 27, 'serum'), ('CL_0000771', 'eosinophil', 39, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 63, 'IgE'), ('CHEBI_50904', 'allergen', 68, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 86, 'IgE'), ('CHEBI_46662', 'mineral', 109, 'mite'), ('NCBITaxon_33208', 'Metazoa', 147, 'cockroach'), ('NCBITaxon_1', 'root', 158, 'tree')]
PMC4896250	4/2016	S3538-PMC4896250	['results: there were no significant differences in the Serum total Eosinophil count, total ige levels between ar patients and ar patients with ba.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CL_0000771', 'eosinophil', 66, 'eosinophil')]
PMC4896250	4/2016	S3674-PMC4896250	['the mean total Ig e level and Eosinophil count was higher in Food allergy group (362.1 ± 555.0 iu/ml, 4.1 ± 3.2%) than no Food allergy group (241.6 ± 414.4, 3.5 ± 2.9; p< 0.001) the risk factors of Food allergy in multivariate logistic regression were asthma history (or, 1.465; 95% ci, 1.078-1.991), atopic dermatitis history (2.841; 2.334-3.458), father and mother Food allergy history (1.764; 1.189-2.617 and 2.009;1.342-3.009), and Breast Milk Feeding for more than 7 months (1.359; 1.110-1.663).']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 15, 'Ig'), ('CL_0000771', 'eosinophil', 30, 'eosinophil'), ('CHEBI_33290', 'food', 61, 'food'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_33290', 'food', 198, 'food'), ('CHEBI_33290', 'food', 367, 'food'), ('GO_0007567', 'parturition', 436, 'breast'), ('UBERON_0000310', 'breast', 436, 'breast'), ('GO_0007614', 'short-term memory', 443, 'milk'), ('UBERON_0001913', 'milk', 443, 'milk'), ('GO_0007631', 'feeding behavior', 448, 'feeding')]
PMC4896250	4/2016	S3716-PMC4896250	['five patients (20.8%) showed Subserosal Eosinophilic infiltration or Eosinophilia in Ascites or surgical biopsy, and 1 patient with muscular Eosinophilic infiltration was revealed by surgical biopsy.']	N/A	N/A	[('UBERON_0001155', 'colon', 29, 'subserosal'), ('CL_0000771', 'eosinophil', 40, 'eosinophilic'), ('CL_0000771', 'eosinophil', 69, 'eosinophilia'), ('UBERON_0004529', 'anatomical projection', 85, 'ascites'), ('CL_0000771', 'eosinophil', 141, 'eosinophilic')]
PMC4896250	4/2016	S3989-PMC4896250	['a280 Cephalosporin-induced dress (Drug rash with Eosinophilia and systemic symptoms) syndrome in a 7-year-old boy\n\nheejeong kang, hyeon-jong yang, taek-ki min, bok-yang pyun\n\nsoonchunhyang university college of medicine, south korea\n\ncorrespondence: heejeong kang – soonchunhyang university college of medicine, south korea\na 7-year-old boy with acute osteomyelitis in right distal Tibia, was treated by the combination of intravenous (iv) Vancomycin and Cefotaxime.']	N/A	N/A	[('CHEBI_23066', 'cephalosporin', 5, 'Cephalosporin'), ('CHEBI_23888', 'drug', 34, 'Drug'), ('CL_0000771', 'eosinophil', 49, 'Eosinophilia'), ('UBERON_0000979', 'tibia', 382, 'tibia'), ('CHEBI_28001', 'vancomycin', 440, 'vancomycin'), ('CHEBI_3533', 'cephaeline', 455, 'cefotaxime')]
PMC4896250	4/2016	S3992-PMC4896250	['laboratory test performed on day 20threvealed marked Eosinophilia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 53, 'eosinophilia')]
PMC4896250	4/2016	S4018-PMC4896250	['the rate of total Ige over than 45 iu/ml was 66.9% and Eosinophil count over than 470 /μl was 26.6%.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 18, 'IgE'), ('CL_0000771', 'eosinophil', 55, 'eosinophil')]
PMC4896250	4/2016	S4029-PMC4896250	['we present a case of 16-year-old boy, who developed an idiopathic aep with no peripheral Eosinophilia, marked Eosinophilia in Balf (36.6%), decreased dlco (75%), typical radiologic findings, and dramatically improved after Corticosteroid treatment without use of Antibiotics.']	N/A	N/A	[('CL_0000771', 'eosinophil', 89, 'eosinophilia'), ('CL_0000771', 'eosinophil', 110, 'eosinophilia'), ('UBERON_0001348', 'brown adipose tissue', 126, 'BALF'), ('CHEBI_36916', 'cation', 223, 'corticosteroid'), ('CHEBI_33282', 'antibacterial agent', 263, 'antibiotics')]
PMC4896250	4/2016	S4078-PMC4896250	['their diagnoses were asthma (31.1%), allergic rhinitis (37.1%), non-allergic rhinitis (7.0%), chronic rhinosinusitis (18.9%), Eosinophilic bronchitis (7.5%), and chronic obstructive Pulmonary disease (1.2%).']	N/A	N/A	[('CL_0000771', 'eosinophil', 126, 'eosinophilic'), ('UBERON_0002048', 'lung', 182, 'pulmonary')]
PMC4896250	4/2016	S4082-PMC4896250	['there was no association between Airway Eosinophilic inflammation and sensitization to any Aeroallergen.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 33, 'airway'), ('CL_0000771', 'eosinophil', 40, 'eosinophilic'), ('CHEBI_2500', 'Aescin', 91, 'aeroallergen')]
PMC4896250	4/2016	S4254-PMC4896250	['inhibition of Autophagy by 3-Ma treatment and atg5 knockdown could induce significant improvement of ahr, Eosinophilia and Il-5 levels in Bal Fluid and Airway inflammation in histology.']	N/A	N/A	[('GO_0006914', 'autophagy', 14, 'autophagy'), ('CHEBI_31035', '1,2-bis(4-hydroxyphenyl)propan-2-ol', 27, '3-MA'), ('CL_0000771', 'eosinophil', 106, 'eosinophilia'), ('PR_000001470', 'interleukin-28B', 123, 'IL-5'), ('UBERON_0006310', 'vitelline venous plexus', 138, 'BAL fluid'), ('UBERON_0001005', 'respiratory airway', 152, 'airway')]
PMC4896250	4/2016	S4255-PMC4896250	['anti-Il-5 Antibody treatment significantly reduced Eosinophil counts and Il-5 levels in Bal Fluid, as well as Lc3 Expression in the Lung Tissue homogenate.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-5'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody'), ('CL_0000771', 'eosinophil', 51, 'eosinophil'), ('PR_000001470', 'interleukin-28B', 73, 'IL-5'), ('UBERON_0006310', 'vitelline venous plexus', 88, 'BAL fluid'), ('PR_000009691', 'protein LBH', 110, 'LC3'), ('GO_0010467', 'gene expression', 114, 'expression'), ('UBERON_0002048', 'lung', 132, 'lung'), ('UBERON_0000479', 'tissue', 137, 'tissue')]
PMC4896250	4/2016	S4296-PMC4896250	['no significant difference was noted in Sputum Eosinophil count according to each genotype.']	N/A	N/A	[('UBERON_0007311', 'sputum', 39, 'sputum'), ('CL_0000771', 'eosinophil', 46, 'eosinophil')]
PMC4896250	4/2016	S4333-PMC4896250	['the Eosinophil counts in the Nasal smears were checked before and after the 4-week treatment.']	N/A	N/A	[('CL_0000771', 'eosinophil', 4, 'eosinophil'), ('UBERON_0000004', 'nose', 29, 'nasal')]
PMC4896250	4/2016	S4337-PMC4896250	['the Serum Il-4 level and Eosinophil counts in the Nasal smears were significantly decreased both in the Antihistamine and the krg groups.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('PR_000001470', 'interleukin-28B', 10, 'IL-4'), ('CL_0000771', 'eosinophil', 25, 'eosinophil'), ('UBERON_0000004', 'nose', 50, 'nasal'), ('CHEBI_2667', 'Amitriptyline hydrochloride', 104, 'antihistamine')]
PMC4896250	4/2016	S4356-PMC4896250	['in vitro test, total Ige and Blood Eosinophil count was analysed.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 21, 'IgE'), ('UBERON_0000178', 'blood', 29, 'blood'), ('CL_0000771', 'eosinophil', 35, 'eosinophil')]
PMC4896250	4/2016	S4358-PMC4896250	['the visual analogue scale of Nasal symptoms were no difference between two groups as in vitro test, total Ige and Blood Eosinophil count.']	N/A	N/A	[('UBERON_0000004', 'nose', 29, 'nasal'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 106, 'IgE'), ('UBERON_0000178', 'blood', 114, 'blood'), ('CL_0000771', 'eosinophil', 120, 'eosinophil')]
PMC4896250	4/2016	S4624-PMC4896250	['allergic symptoms and Eosinophils in Nasal Mucosa, Interferone-Γ, Interleukin (Il)-4, Il-9, Il-17, Tgf-Ss, Il-10, T-Bet, Gata-3, Ror- γ t and Foxp3 mrna Expression in Nasal Mucosa and Serum ova-specific Ige were measured.']	N/A	N/A	[('CL_0000771', 'eosinophil', 22, 'eosinophils'), ('UBERON_0000331', 'ileal mucosa', 37, 'nasal mucosa'), ('PR_000002050', 'interferon regulatory factor 8', 51, 'interferone-γ'), ('PR_000001470', 'interleukin-28B', 66, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 79, 'IL)-4'), ('PR_000001470', 'interleukin-28B', 86, 'IL-9'), ('PR_000001470', 'interleukin-28B', 92, 'IL-17'), ('PR_000000046', 'TGF-beta', 99, 'TGF-ß'), ('PR_000001470', 'interleukin-28B', 106, 'IL-10'), ('PR_000016190', 'trichohyalin-like protein 1', 113, 'T-bet'), ('PR_000007857', 'erythroid transcription factor', 120, 'GATA-3'), ('PR_000014160', 'ropporin-1-like protein', 128, 'ROR- γ'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 141, 'Foxp3'), ('GO_0010467', 'gene expression', 152, 'expression'), ('UBERON_0000331', 'ileal mucosa', 166, 'nasal mucosa'), ('UBERON_0001977', 'blood serum', 183, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 202, 'IgE')]
PMC4896250	4/2016	S4625-PMC4896250	['results: Serum ova-specific Ige and Eosinophil counts were significantly decreased in anti-Il-9 Ab group compared with it group (p<0.05).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'Serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 28, 'IgE'), ('CL_0000771', 'eosinophil', 36, 'Eosinophil'), ('PR_000001470', 'interleukin-28B', 91, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 96, 'Ab')]
PMC4896250	4/2016	S4664-PMC4896250	['ninety ad children, aged between 6 and 12 years, completed scoring of severity of ad (scorad), Blood tests for Serum total Ige, Blood Eosinophil counts, Serum Eosinophil Cationic protein (ecp) and Lipid profiles.']	N/A	N/A	[('UBERON_0000178', 'blood', 95, 'blood'), ('UBERON_0001977', 'blood serum', 111, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 123, 'IgE'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000771', 'eosinophil', 134, 'eosinophil'), ('UBERON_0001977', 'blood serum', 153, 'serum'), ('CL_0000771', 'eosinophil', 159, 'eosinophil'), ('CHEBI_36916', 'cation', 170, 'cationic'), ('CHEBI_18059', 'lipid', 197, 'lipid')]
PMC4896250	4/2016	S4704-PMC4896250	['methods\nin 2012, Serum Eosinophil, ecp, and tige were measured in 3rd and 4th grade students of 5 elementary schools.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 17, 'serum'), ('CL_0000771', 'eosinophil', 23, 'eosinophil')]
PMC4896250	4/2016	S4708-PMC4896250	['the cut off value and usefulness of serologic markers (Serum Eosinophil, ecp, and tige) were calculated using the receiver operating characteristic curve.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CL_0000771', 'eosinophil', 61, 'eosinophil')]
PMC4896250	4/2016	S4805-PMC4896250	['both of wsc and Probiotic extracts treatment moderated allergic inflammation including a decreased level of total and Der P-specific Ige in the Serum, lowered Expressions of il-4, Il-5, and Il-13 in Nasal Lavage Fluid, as well as less Eosinphil infiltration in the Nasal Cavity.']	N/A	N/A	[('CHEBI_73033', 'pterocarpan', 16, 'probiotic'), ('PR_000006266', 'dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1', 118, 'Der p'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 133, 'IgE'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('GO_0010467', 'gene expression', 159, 'expressions'), ('PR_000000164', 'BMP2', 176, '-4'), ('PR_000001470', 'interleukin-28B', 180, 'IL-5'), ('PR_000001470', 'interleukin-28B', 190, 'IL-13'), ('UBERON_0000307', 'blastula', 199, 'nasal lavage fluid'), ('CL_0000771', 'eosinophil', 235, 'eosinphil'), ('UBERON_0001707', 'nasal cavity', 265, 'nasal cavity')]
PMC4896250	4/2016	S4898-PMC4896250	['the issac questionnaire, Serum total Ige level, Blood Eosinophil percentage, skin prick test, Pulmonary function test and Methacholine challenge test were done at age 7 for baseline and age 11 years after follow up.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 37, 'IgE'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CL_0000771', 'eosinophil', 54, 'eosinophil'), ('UBERON_0002048', 'lung', 94, 'pulmonary'), ('CHEBI_6805', 'methacycline', 122, 'methacholine')]
PMC4896250	4/2016	S4905-PMC4896250	['Eosinophil percent (aor=1.280, 95% ci 1.123-1.458), logige (aor=2.757, 95% ci 1.443-5.269), and atopic sensitization (aor=2.461, 95% ci 1.163-5.208) at age 7 years were risk factors for bhr persistent group.']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophil')]
PMC4896250	4/2016	S4910-PMC4896250	['children with bhr new showed high sensitization and normal Lung function, but low Eosinophil at age 7 yrs.']	N/A	N/A	[('UBERON_0002048', 'lung', 59, 'lung'), ('CL_0000771', 'eosinophil', 82, 'eosinophil')]
PMC4896250	4/2016	S4975-PMC4896250	['laboratory investigations revealed positive anti-Nuclear Antibody in 26% (12/47; none with anti-Thyroid Antibodies), circulating Eosinophilia in 24% (14/59), increased Serum total Ige in 68% (40/59) and low Plasma C3 and/or c4 levels in 30% (16/53).']	N/A	N/A	[('GO_0005634', 'nucleus', 49, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody'), ('UBERON_0002046', 'thyroid gland', 96, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 104, 'antibodies'), ('CL_0000771', 'eosinophil', 129, 'eosinophilia'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 180, 'IgE'), ('UBERON_0001969', 'blood plasma', 207, 'plasma'), ('PR_000004904', 'complement C5', 214, 'C3')]
PMC4896250	4/2016	S5017-PMC4896250	['geometric means (range of 1 sd) of Blood Eosinophil percentage (5.78% [3.35-10.00]) and Serum Eosinophil Cationic protein concentration (48.98 μg/l [43.84-2,189.52]) in severe ad group were significantly higher than those of mild-to-moderate ad group (3.64% [1.67-7.96], 33.28 μg/l [12.02-92.20]).']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000771', 'eosinophil', 41, 'eosinophil'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('CL_0000771', 'eosinophil', 94, 'eosinophil'), ('CHEBI_36916', 'cation', 105, 'cationic')]
PMC4896250	4/2016	S5402-PMC4896250	['results: edn and th2 cytokines are significantly higher in ecrs than non-Eosinophilic crs (necrs).']	N/A	N/A	[('CL_0000771', 'eosinophil', 73, 'eosinophilic')]
PMC4896250	4/2016	S5536-PMC4896250	['patients Blood Eosinophils Leukocyte count, levels of total sesrum Imunoglobulin e, Serum Eosinophil Cationic protein and exhaled Nitric Oxide levels were determined.daily the patients received 1500 iu of Vitamin D3 orally.']	N/A	N/A	[('UBERON_0000178', 'blood', 9, 'blood'), ('CL_0000771', 'eosinophil', 15, 'eosinophils leukocyte'), ('GO_0019814', 'immunoglobulin complex', 67, 'imunoglobulin'), ('UBERON_0001977', 'blood serum', 84, 'serum'), ('CL_0000771', 'eosinophil', 90, 'eosinophil'), ('CHEBI_36916', 'cation', 101, 'cationic'), ('CHEBI_16480', 'nitric oxide', 130, 'nitric oxide'), ('CHEBI_33237', 'vitamin D4', 205, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 205, 'Vitamin D3')]
PMC4896250	4/2016	S5632-PMC4896250	['the treatment of Mice with established allergy led to attenuation of Eosinophilia, th2 cytokines and Airway hyperresponsiveness.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 17, 'mice'), ('CL_0000771', 'eosinophil', 69, 'eosinophilia'), ('UBERON_0001005', 'respiratory airway', 101, 'airway')]
PMC4896250	4/2016	S5715-PMC4896250	['we also measured Eosinophilic count, total Ige and specific Ige in Peripheral Blood.']	N/A	N/A	[('CL_0000771', 'eosinophil', 17, 'Eosinophilic'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 43, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 60, 'IgE'), ('UBERON_0012101', 'perinatal stage', 67, 'peripheral blood')]
PMC4896250	4/2016	S5913-PMC4896250	['a417 exhaled Nitric Oxide in korean children with allergic rhinitis\n\nseung hyun moon\n\ninha university hospital south korea\na) background: fractional concentration of No in exhaled Breath (Feno) is mainly used to evaluate the Eosinophilic inflammation in asthma.']	N/A	N/A	[('CHEBI_44445', 'nimesulide', 13, 'Nitric Oxide'), ('CHEBI_16382', 'iodide', 166, 'NO'), ('UBERON_0000310', 'breast', 180, 'breath'), ('CHEBI_32035', 'potassium hydroxide', 188, 'FeNO'), ('CL_0000771', 'eosinophil', 225, 'eosinophilic')]
PMC4896250	4/2016	S5967-PMC4896250	['a422 Sputum Microbiota in chinese Adults with Eosinophilic versus non-Eosinophilic asthma\n\nqingling zhang1, rihuang qiu1, naijian li1, zhaowei yang2, jing li3, kian fan chung4, nanshan zhong5\n\n1guangzhou institute of respiratory disease, china;2department of allergy and clinical immunology, state key laboratory of respiratory disease, china;3state key laboratory of respiratory disease, the first affiliated hospital, guangzhou medical university, china;4imperial college of science, tech.']	N/A	N/A	[('UBERON_0007311', 'sputum', 5, 'Sputum'), ('CHEBI_82142', 'Mipafox', 12, 'Microbiota'), ('UBERON_0007023', 'adult organism', 34, 'Adults'), ('CL_0000771', 'eosinophil', 46, 'Eosinophilic'), ('CL_0000771', 'eosinophil', 70, 'Eosinophilic')]
PMC4896250	4/2016	S5975-PMC4896250	['results: asthmatics had lower fev1% predicted (72.2% vs. 98.6%, p<0.001) and higher Sputum Eosinophil (13.0% vs. 0.5%, p<0.001) compared to healthy controls.']	N/A	N/A	[('UBERON_0007311', 'sputum', 84, 'sputum'), ('CL_0000771', 'eosinophil', 91, 'eosinophil')]
PMC4896250	4/2016	S5978-PMC4896250	['subjects with eosinopihilic asthma (ea) are older and have shorter duration of asthma (9.6 vs. 19.2 years, p=0.041) as well as lower fev1% (69.3% vs. 79.2%, p<0.001) compared to subjects with non-Eosinopihilic asthma (nea).']	N/A	N/A	[('CL_0000771', 'eosinophil', 196, 'eosinopihilic')]
PMC4896250	4/2016	S6019-PMC4896250	['there were no significant differences in sex, age, smoking habits, levels of Eosinophil of Serum and Sputum, and baseline Lung function.']	N/A	N/A	[('CL_0000771', 'eosinophil', 77, 'eosinophil'), ('UBERON_0001977', 'blood serum', 91, 'serum'), ('UBERON_0007311', 'sputum', 101, 'sputum'), ('UBERON_0002048', 'lung', 122, 'lung')]
PMC4896250	4/2016	S6021-PMC4896250	['total Ige and Sputum Eosinophil was much more decreased in group i compared with group ii.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 6, 'IgE'), ('UBERON_0007311', 'sputum', 14, 'sputum'), ('CL_0000771', 'eosinophil', 21, 'eosinophil')]
PMC4896250	4/2016	S6224-PMC4896250	['in his laboratory finding, peripheral wbc count was 21,600 mm3with 60% Eosinophilia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 71, 'eosinophilia')]
PMC4896250	4/2016	S6232-PMC4896250	['she has been treated for Eosinophilic gastritis on the endoscope for one month at another hospital.']	N/A	N/A	[('CL_0000771', 'eosinophil', 25, 'eosinophilic')]
PMC4896250	4/2016	S6235-PMC4896250	['wbc count was 6750 mm3with 5.5 % Eosinophilia.']	N/A	N/A	[('CL_0000771', 'eosinophil', 33, 'eosinophilia')]
PMC4896250	4/2016	S6362-PMC4896250	['skin rash, fever, Eosinophilia, and elevations of Liver enzymes improved with conservative treatment and discontinuation of the causative Drugs.']	N/A	N/A	[('CL_0000771', 'eosinophil', 18, 'eosinophilia'), ('UBERON_0002107', 'liver', 50, 'liver'), ('CHEBI_23888', 'drug', 138, 'drugs')]
PMC4896250	4/2016	S6398-PMC4896250	['a450 epidemiological characterization of Blood Eosinophils in the elderly population\n\nha kyeong won1, hye-ryun kang1, byung-keun kim2, sung do moon1, ju-young kim1, so-hee lee1, woo-jung song3, heung woo park3, min-koo kang1, sun-sin kim1, sang-heon cho4, kyung-up min4, yoon-seok chang3, kyoung hee sohn3, kyung-mook kim5, ki-woong kim2, hak chul jang2\n\n1seoul national university hospital, south korea;2seoul national university bundang hospital;3seoul national university college of medicine;4seoul national university medical research center;5pogunhan mom hospital\n\ncorrespondence: ha kyeong won – seoul national university hospital, south korea\nbackground: peripheral Blood Eosinophilia is a common clinical manifestation which draws medical attention.']	N/A	N/A	[('UBERON_0000178', 'blood', 41, 'Blood'), ('CL_0000771', 'eosinophil', 47, 'Eosinophils'), ('UBERON_0000178', 'blood', 673, 'blood'), ('CL_0000771', 'eosinophil', 679, 'eosinophilia')]
PMC4896250	4/2016	S6402-PMC4896250	['the primary outcome was peripheral Blood Eosinophil counts and the upper limit of the 95% confidence interval for absolute count of Blood Eosinophil counts was calculated for normal ranges.']	N/A	N/A	[('UBERON_0000178', 'blood', 35, 'blood'), ('CL_0000771', 'eosinophil', 41, 'eosinophil'), ('UBERON_0000178', 'blood', 132, 'blood'), ('CL_0000771', 'eosinophil', 138, 'eosinophil')]
PMC4896250	4/2016	S6406-PMC4896250	['results: cutoff value for Blood Eosinophilia was less than 406.6x103/ml (n=1,000).']	N/A	N/A	[('UBERON_0000178', 'blood', 26, 'blood'), ('CL_0000771', 'eosinophil', 32, 'eosinophilia')]
PMC4896250	4/2016	S6412-PMC4896250	['conclusion: the normal range of Peripheral Blood Eosinophils in the korean elderly was ≤ 406.6 x103/ml (upper 95th percentile), which was almost identical to the reference range in the literature.']	N/A	N/A	[('UBERON_0012101', 'perinatal stage', 32, 'peripheral'), ('UBERON_0000178', 'blood', 43, 'blood'), ('CL_0000771', 'eosinophil', 49, 'eosinophils')]
PMC4896250	4/2016	S6619-PMC4896250	['relationships among Sputum Il-32, Airway obstruction (fev1), inflammation (Neutrophil and Eosinophil % of the Airway) and exacerbation frequency were evaluated.']	N/A	N/A	[('UBERON_0007311', 'sputum', 20, 'sputum'), ('PR_000001470', 'interleukin-28B', 27, 'IL-32'), ('UBERON_0001005', 'respiratory airway', 34, 'airway'), ('CL_0000775', 'neutrophil', 75, 'neutrophil'), ('CL_0000771', 'eosinophil', 90, 'eosinophil'), ('UBERON_0001005', 'respiratory airway', 110, 'airway')]
PMC4896250	4/2016	S6622-PMC4896250	['when the all subjects were grouped into two inflammatory patterns by Eosinophil% (over 3%, under 3%) or Neutrophils% (over 70%, under 70%), Il-32 levels was not different by the inflammatory patterns.']	N/A	N/A	[('CL_0000771', 'eosinophil', 69, 'eosinophil'), ('CL_0000775', 'neutrophil', 104, 'Neutrophils'), ('PR_000001470', 'interleukin-28B', 140, 'IL-32')]
PMC4896250	4/2016	S6778-PMC4896250	['we calculate the ratio of Eosinophils, the level of non-specific and specific Ige, and so on.']	N/A	N/A	[('CL_0000771', 'eosinophil', 26, 'eosinophils'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 78, 'IgE')]
PMC4896250	4/2016	S6782-PMC4896250	['we measured the ratio of Eosinophils, the level of non-specific and specific Ige, and so on.']	N/A	N/A	[('CL_0000771', 'eosinophil', 25, 'eosinophils'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE')]
PMC4896250	4/2016	S6802-PMC4896250	['laboratory\nEosinophils %13.83 (0.5-11.0),total ig e: 138 iu/ml (1.31-165.3) specific Ig e ( mixed 5 ) (Food panel 2): (Morino fish, prawn, shell, Tuna fish, salmon fish): 26.5 ku/l (0-0.35 ku/l), wchich indicates strong positive result.inasmuch as our patient had allergic rhinitis, a skin-prick test with Respiratory Allergen panel was conducted in order to determine the causative inhalatory Allergen.']	N/A	N/A	[('CL_0000771', 'eosinophil', 11, 'Eosinophils'), ('GO_0071735', 'IgG immunoglobulin complex', 85, 'Ig'), ('CHEBI_33290', 'food', 103, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'morino'), ('NCBITaxon_10088', 'Mus <genus>', 146, 'tuna'), ('UBERON_0001004', 'respiratory system', 306, 'respiratory'), ('CHEBI_50904', 'allergen', 318, 'allergen'), ('CHEBI_50904', 'allergen', 394, 'allergen')]
PMC4896250	4/2016	S6829-PMC4896250	['in previous experiments of Mice, a short-term exposure to staphylococcal enterotoxin b (seb) induced extensive inflammatory responses in Lungs, including Lymphocytes, Neutrophils and Eosinophils.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 27, 'mice'), ('UBERON_0002048', 'lung', 137, 'lungs'), ('CL_0000542', 'lymphocyte', 154, 'lymphocytes'), ('CL_0000775', 'neutrophil', 167, 'neutrophils'), ('CL_0000771', 'eosinophil', 183, 'eosinophils')]
PMC4896250	4/2016	S6897-PMC4896250	['laboratory tests including Serum total Ige, Eosinophil(%), and specific Ige to Egg white, Milk, Soy, wheat, and Peanut were measured.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 27, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 39, 'IgE'), ('CL_0000771', 'eosinophil', 44, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 72, 'IgE'), ('UBERON_0007379', 'shelled egg', 79, 'egg'), ('UBERON_0001913', 'milk', 90, 'milk'), ('NCBITaxon_1', 'root', 96, 'soy'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'peanut')]
PMC4896250	4/2016	S6901-PMC4896250	['children with having fa had a higher Blood total Ige levels(238.7±414.6 iu/ml vs. 50.7±96.0 iu/ml, p =0.001) and Eosinophil(%)(7.0% ± 5.0% vs. 4.7% ±3.4%, p =0.001), and more frequent parental allergic history(70% vs. 59%, p =0.025).']	N/A	N/A	[('UBERON_0000178', 'blood', 37, 'blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 49, 'IgE'), ('CL_0000771', 'eosinophil', 113, 'eosinophil')]
PMC4896250	4/2016	S6944-PMC4896250	['Sputum eosinophilia was defined as induced Sputum Eosinophils≥3%.']	N/A	N/A	[('UBERON_0007311', 'sputum', 0, 'Sputum'), ('UBERON_0007311', 'sputum', 43, 'sputum'), ('CL_0000771', 'eosinophil', 50, 'eosinophils')]
PMC4896250	4/2016	S6945-PMC4896250	['the diagnostic utility was assessed using receiver operating curve (roc) analyses for Blood Eosinophils in predicting Sputum eosinophilia.']	N/A	N/A	[('UBERON_0000178', 'blood', 86, 'blood'), ('CL_0000771', 'eosinophil', 92, 'eosinophils'), ('UBERON_0007311', 'sputum', 118, 'sputum')]
PMC4896250	4/2016	S6988-PMC4896250	['levels of Blood Nitric Oxide (Nox), High Mobility Group Box-1 (Hmgb-1), thioredoxin, and Eosinophil-derived neurotoxin and Urine 8-Hydroxydeoxyguanosine (8-Ohdg), Nox, Biopyrrin, and 8-Isoprostanes were measured on admission day(acute phase), on hospital days 3–5(recovery phase), and 1–2 weeks after discharge(late phase).']	N/A	N/A	[('UBERON_0000178', 'blood', 10, 'blood'), ('CHEBI_16480', 'nitric oxide', 16, 'nitric oxide'), ('CHEBI_26710', 'sodium chloride', 30, 'NOx'), ('PR_000008629', 'high mobility group protein HMGI-C', 36, 'high mobility group box-1'), ('PR_000008650', 'jupiter microtubule associated homolog 1', 63, 'HMGB-1'), ('CL_0000771', 'eosinophil', 89, 'eosinophil'), ('UBERON_0001088', 'urine', 123, 'urine'), ('CHEBI_24909', 'hydrocarbyladenosine', 131, 'hydroxydeoxyguanosine'), ('CHEBI_78732', '9-HPETE', 154, '8-OHdG'), ('CHEBI_26710', 'sodium chloride', 163, 'NOx'), ('CHEBI_3093', 'bifenthrin', 168, 'biopyrrin'), ('CHEBI_38773', 'quinolinemonocarboxylate', 183, '8-isoprostanes')]
PMC4896250	4/2016	S7229-PMC4896250	['there was no significant association between treatment response and laboratory parameters including peak Tec, total Ige, Eosinophil Cationic protein or Marrow Eosinophilia.']	N/A	N/A	[('CL_0002293', 'epithelial cell of thymus', 105, 'TEC'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 116, 'IgE'), ('CL_0000771', 'eosinophil', 121, 'eosinophil'), ('CHEBI_36916', 'cation', 132, 'cationic'), ('UBERON_0002371', 'bone marrow', 152, 'marrow'), ('CL_0000771', 'eosinophil', 159, 'eosinophilia')]
PMC4896250	4/2016	S7235-PMC4896250	['Eosinophilic asthma(ea) and Eosinophilic asthma Dexamethasone intervention(ead) Mice were sensitized through the Peritoneum with ova and Aluminum Hydroxide.']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilic'), ('CL_0000771', 'eosinophil', 28, 'eosinophilic'), ('CHEBI_41879', 'dexamethasone', 48, 'dexamethasone'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mice'), ('UBERON_0003055', 'periderm', 113, 'peritoneum'), ('CHEBI_33130', 'aluminium hydroxide', 137, 'aluminum hydroxide')]
PMC4896250	4/2016	S7332-PMC4896250	['we evaluated Airway hyperresponsiveness (ahr), the proportion of Eosinophils in Bronchoalveolar Lavage Fluid (Balf), Lung histology, Serum total and ova-specific Antibody, cytokine profile of Balf and Lung draining Lymph Nodes (Lln), and T Cell population of lln.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 13, 'airway'), ('CL_0000771', 'eosinophil', 65, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 80, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 110, 'BALF'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 162, 'antibody'), ('UBERON_0001348', 'brown adipose tissue', 192, 'BALF'), ('UBERON_0002048', 'lung', 201, 'lung'), ('UBERON_0000029', 'lymph node', 215, 'lymph nodes'), ('UBERON_2000120', 'lateral line ganglion', 228, 'LLN'), ('CL_0000084', 'T cell', 238, 'T cell')]
PMC4896250	4/2016	S7333-PMC4896250	['results: Ascs-derived secretome significantly inhibited Eosinophilic inflammation in the Lung.']	N/A	N/A	[('CL_0002561', 'outer root sheath cell', 9, 'ASCs'), ('CL_0000771', 'eosinophil', 56, 'eosinophilic'), ('UBERON_0002048', 'lung', 89, 'lung')]
PMC4896250	4/2016	S7334-PMC4896250	['ahr, total Immune Cell and Eosinophils in the Balf, and Mucus Production were significantly reduced after Ascs-derived secretome administration.']	N/A	N/A	[('CL_0000738', 'leukocyte', 11, 'immune cell'), ('UBERON_0002405', 'immune system', 11, 'immune'), ('CL_0000771', 'eosinophil', 27, 'eosinophils'), ('UBERON_0001348', 'brown adipose tissue', 46, 'BALF'), ('GO_0007498', 'mesoderm development', 56, 'mucus production'), ('UBERON_0000912', 'mucus', 56, 'mucus'), ('CL_0002561', 'outer root sheath cell', 106, 'ASCs')]
PMC4896250	4/2016	S7358-PMC4896250	['also, the medians of the tarc levels, the peripheral Eosinophil counts, and the Serum ldh levels were 2213pg/dl (range, 514-21776 pg/dl), 6%(range 0%-18%), and 290iu/ml(range 211-432 iu/ml), respectively.']	N/A	N/A	[('CL_0000771', 'eosinophil', 53, 'eosinophil'), ('UBERON_0001977', 'blood serum', 80, 'serum')]
PMC4896250	4/2016	S7540-PMC4896250	['all Tissues were microscopically examined for the presence of Eosinophilia (10≥high power field).']	N/A	N/A	[('UBERON_0000479', 'tissue', 4, 'tissues'), ('CL_0000771', 'eosinophil', 62, 'eosinophilia')]
PMC4896250	4/2016	S7541-PMC4896250	['Blood Eosinophil count and Serum levels of total Ige, specific Ige to Tsst-1 and Eosinophil Cationic protein (ecp) using immunocap were analyzed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 27, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 49, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 63, 'IgE'), ('PR_000016759', 'testis-specific Y-encoded protein 2', 70, 'TSST-1'), ('CL_0000771', 'eosinophil', 81, 'eosinophil'), ('CHEBI_36916', 'cation', 92, 'cationic')]
PMC4896250	4/2016	S7542-PMC4896250	['results: fifty six crs without np (47 non-Eosinophilic and 9 eosinophilic) and 165 crs with np (114 non-Eosinophilic and 51 eosinophilic) patients were included.']	N/A	N/A	[('CL_0000771', 'eosinophil', 42, 'eosinophilic'), ('CL_0000771', 'eosinophil', 104, 'eosinophilic')]
PMC4896250	4/2016	S7543-PMC4896250	['the level of Blood Eosinophil count, total Ige and ecp were not significantly different, but Serum specific Ige to Tsst-1 was different between crs with np and without np (p=0.26).']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('CL_0000771', 'eosinophil', 19, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 43, 'IgE'), ('UBERON_0001977', 'blood serum', 93, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 108, 'IgE'), ('PR_000016759', 'testis-specific Y-encoded protein 2', 115, 'TSST-1')]
PMC4896250	4/2016	S7544-PMC4896250	['positive rate of Serum specific Ige to Tsst-1 was higher in Eosinophilic crs with np (54.9%) than crs without np (23.2%) and noneosinophilic crs with np (25.4%) (p=0.001).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 17, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 32, 'IgE'), ('PR_000016759', 'testis-specific Y-encoded protein 2', 39, 'TSST-1'), ('CL_0000771', 'eosinophil', 60, 'Eosinophilic')]
PMC4896250	4/2016	S7569-PMC4896250	['laboratory test results showed an elevated Blood Eosinophil count (1800 /mm3) and an elevated Serum specific Ige level to strawberry (measured by immunocap® [thermofisher scientific, uppsala, sweden] system, 3.98 ku/l).']	N/A	N/A	[('UBERON_0000178', 'blood', 43, 'blood'), ('CL_0000771', 'eosinophil', 49, 'eosinophil'), ('UBERON_0001977', 'blood serum', 94, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 109, 'IgE')]
PMC4896250	4/2016	S7572-PMC4896250	['after using systemic Corticosteroid and Antihistamines, Blood Eosinophil count decreased to normal range and the patient’s symptoms were resolved.']	N/A	N/A	[('CHEBI_36916', 'cation', 21, 'corticosteroid'), ('CHEBI_22581', 'antiauxins', 40, 'antihistamines'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CL_0000771', 'eosinophil', 62, 'eosinophil')]
PMC4896250	4/2016	S7574-PMC4896250	['Blood Eosinophil count was 900 /mm3and Serum specific Ige levels to pineapple, celery, and sesame were 0.68 ku/l, 0.93 ku/l, and 0.77 ku/l, respectively.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 39, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 54, 'IgE')]
PMC4896250	4/2016	S7576-PMC4896250	['Blood Eosinophil count was 1,600 /mm3and Serum specific Ige level to almond was 4.63 ku/l.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('CL_0000771', 'eosinophil', 6, 'eosinophil'), ('UBERON_0001977', 'blood serum', 41, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 56, 'IgE')]
PMC4896250	4/2016	S7628-PMC4896250	['Bal levels of Lymphocytes, Neutrophils and Eosinophils decreased significantly (p<0.01) in Mice receiving anti-Il-4Ra loaded nanocarriers.']	N/A	N/A	[('UBERON_0006378', 'strand of vibrissa hair', 0, 'BAL'), ('CL_0000542', 'lymphocyte', 14, 'lymphocytes'), ('CL_0000775', 'neutrophil', 27, 'neutrophils'), ('CL_0000771', 'eosinophil', 43, 'eosinophils'), ('NCBITaxon_10088', 'Mus <genus>', 91, 'mice'), ('PR_000001366', 'interleukin-11', 111, 'IL-4Ra')]
PMC4896250	4/2016	S7641-PMC4896250	['the numbers of positive Allergen skin responses and some Blood tests for Eosinophil count, total Ige, esr were collected as well.']	N/A	N/A	[('CHEBI_50904', 'allergen', 24, 'allergen'), ('UBERON_0000178', 'blood', 57, 'blood'), ('CL_0000771', 'eosinophil', 73, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 97, 'IgE')]
PMC4896250	4/2016	S7796-PMC4896250	['the lesions were diagnosed as mc based on histopathologic findings of typical Eosinophilic Cytoplasmic molluscum Inclusion Bodies on the acanthotic Epidermis as well as dermal Inclusion cyst.']	N/A	N/A	[('CL_0000771', 'eosinophil', 78, 'eosinophilic'), ('GO_0005737', 'cytoplasm', 91, 'cytoplasmic'), ('GO_0016234', 'inclusion body', 113, 'inclusion bodies'), ('UBERON_0007376', 'outer epithelium', 148, 'epidermis'), ('GO_0016234', 'inclusion body', 176, 'inclusion')]
PMC4896250	4/2016	S7924-PMC4896250	['the levels were analyzed in terms of Airway obstruction (fev1%) and inflammation (Neutrophil % and Eosinophil % of induced Sputum) and exacerbation frequency and Lung function over 1 year or longer follow up.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 37, 'airway'), ('CL_0000775', 'neutrophil', 82, 'neutrophil'), ('CL_0000771', 'eosinophil', 99, 'eosinophil'), ('UBERON_0007311', 'sputum', 123, 'sputum'), ('UBERON_0002048', 'lung', 162, 'lung')]
PMC4896250	4/2016	S7940-PMC4896250	['the levels were analyzed in terms of Airway obstruction (fev1) and inflammation (Neutrophil and Eosinophil % of the Airway) and exacerbation frequency and Lung functions over 1 year or longer follow up.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 37, 'airway'), ('CL_0000775', 'neutrophil', 81, 'neutrophil'), ('CL_0000771', 'eosinophil', 96, 'eosinophil'), ('UBERON_0001005', 'respiratory airway', 116, 'airway'), ('UBERON_0002048', 'lung', 155, 'lung')]
PMC4896250	4/2016	S7951-PMC4896250	['results: in wt and ido-ko asthmatic Mice, Ascs significantly reduced Airway hyperresponsiveness, total Inflammatory Cells and Eosinophils in the Bronchoalveolar Lavage Fluid (Balf), Eosinophilic inflammation, Goblet Cell hyperplasia, and Serum total and Allergen-specific Ige and Igg1.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('CL_0002561', 'outer root sheath cell', 42, 'ASCs'), ('UBERON_0001005', 'respiratory airway', 69, 'airway'), ('CL_0000902', 'induced T-regulatory cell', 103, 'inflammatory cells'), ('CL_0000771', 'eosinophil', 126, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 145, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 175, 'BALF'), ('CL_0000771', 'eosinophil', 182, 'eosinophilic'), ('CL_0000160', 'goblet cell', 209, 'goblet cell'), ('UBERON_0001977', 'blood serum', 238, 'serum'), ('CHEBI_50904', 'allergen', 254, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 272, 'IgE'), ('GO_0071735', 'IgG immunoglobulin complex', 280, 'IgG1')]
PMC4896250	4/2016	S8128-PMC4896250	['methods: twenty-eight children with exacerbated asthmatics without using any Corticosteroids were divided into three groups: Eosinophilic asthma group (ea group) (n = 12), Neutrophilic asthma group (na group) (n = 10) and paucigranulocytic asthma (pga group) (n = 6) according to induced Sputum cytology.ten healthy children were recruited as healthy control group (hc group) (n =10).']	N/A	N/A	[('CHEBI_50850', 'etabonate ester', 77, 'corticosteroids'), ('CL_0000771', 'eosinophil', 125, 'eosinophilic'), ('CL_0000775', 'neutrophil', 172, 'neutrophilic'), ('UBERON_0007311', 'sputum', 288, 'sputum')]
PMC4896250	4/2016	S8418-PMC4896250	['results: compared with control Mice, the Mice exposed to ova developed sustained Eosinophilic Airway inflammation and Airway hyperresponsiveness (ahr).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 31, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'mice'), ('CL_0000771', 'eosinophil', 81, 'eosinophilic'), ('UBERON_0001005', 'respiratory airway', 94, 'airway'), ('UBERON_0001005', 'respiratory airway', 118, 'airway')]
PMC4896250	4/2016	S8419-PMC4896250	['administration of Nintedanib significantly decreased total cell and Eosinophilic count in Bronchoalveolar Lavage (Bal) Fluid.']	N/A	N/A	[('CHEBI_85164', 'nintedanib', 18, 'nintedanib'), ('CL_0000771', 'eosinophil', 68, 'eosinophilic'), ('UBERON_0013561', 'Brodmann (1909) area 43', 90, 'bronchoalveolar lavage ...'), ('UBERON_0006314', 'bodily fluid', 114, 'BAL ... fluid')]
PMC4896250	4/2016	S8908-PMC4896250	['pre-treatment Eosinophil counts were recorded from peak Eosinophil counts of the most recent biopsy prior to initiation of the elimination diet.']	N/A	N/A	[('CL_0000771', 'eosinophil', 14, 'eosinophil'), ('CL_0000771', 'eosinophil', 56, 'eosinophil')]
PMC4896250	4/2016	S8918-PMC4896250	['spergel jm, brown-whitehorn tf, cianferoni a, shuker m, wang ml, verma r, liacouras ca: identification of causative Foods in children with Eosinophilic Esophagitis treated with an elimination diet.the journal of allergy and clinical immunology 2012, 130: 461–467 e465.']	N/A	N/A	[('CHEBI_33290', 'food', 116, 'foods'), ('CL_0000771', 'eosinophil', 139, 'eosinophilic'), ('UBERON_0001035', 'dento-alveolar joint', 152, 'esophagitis')]
PMC4896250	4/2016	S8943-PMC4896250	['a mild Eosinophilia (7.2%) was detected in Peripheral Blood.']	N/A	N/A	[('CL_0000771', 'eosinophil', 7, 'eosinophilia'), ('UBERON_0012101', 'perinatal stage', 43, 'peripheral'), ('UBERON_0000178', 'blood', 54, 'blood')]
PMC4896250	4/2016	S8949-PMC4896250	['in september 2014 the patient was referred to our unit, we found a peripheral Eosinophilia of 14.4% and, suspecting parasitic infections, we evaluated specific Ige to ascaris, which had a value of 32.50 ku/l, while total Ige were 8324 ku/l.']	N/A	N/A	[('CL_0000771', 'eosinophil', 78, 'eosinophilia'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 160, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 221, 'IgE')]
PMC4896250	4/2016	S8952-PMC4896250	['results one month after the first two cycles of therapy the patient showed a progressive improvement of symptoms, and Eosinophilia was 12%.']	N/A	N/A	[('CL_0000771', 'eosinophil', 118, 'eosinophilia')]
PMC4896250	4/2016	S8953-PMC4896250	['six months after the end of therapy the skin was free from dermatitis and a decrease was observed for Eosinophilia (10.1%) and ascaris-specific Ige (27.50 ku/l).']	N/A	N/A	[('CL_0000771', 'eosinophil', 102, 'eosinophilia'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 144, 'IgE')]
PMC4896250	4/2016	S9129-PMC4896250	['result\nthe number of Eosinophils in Balf was significantly increased in Mice sensitized by hdm with Cgamp.']	N/A	N/A	[('CL_0000771', 'eosinophil', 21, 'eosinophils'), ('UBERON_0001348', 'brown adipose tissue', 36, 'BALF'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('PR_000005000', 'calmodulin-binding transcription activator 1', 100, 'cGAMP')]
PMC4896250	4/2016	S9142-PMC4896250	['laboratory findings showed extremely elevated Ige levels, 64285 iu/ml, absolute Eosinophils 5,400 cells/μl, and a normal tryptase.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 46, 'IgE'), ('CL_0000771', 'eosinophil', 80, 'eosinophils')]
PMC4896250	4/2016	S9149-PMC4896250	['one month after initiating Omalizumab treatment, his dermatitis and Eosinophilia markedly improved.']	N/A	N/A	[('CHEBI_76014', 'dolutegravir(1-)', 27, 'omalizumab'), ('CL_0000771', 'eosinophil', 68, 'eosinophilia')]
PMC4896250	4/2016	S9177-PMC4896250	['wbc were 11,827 ±3,992.3 cells/ul, Eosinophils 955±946.1 cells/ul, and total Ige 3,2598,708.6 ku/l.']	N/A	N/A	[('CL_0000771', 'eosinophil', 35, 'eosinophils'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE')]
PMC4896250	4/2016	S9368-PMC4896250	['Eosinophilia from Blood smear examination was found in 6 cases of da (46,2%).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilia'), ('UBERON_0000178', 'blood', 18, 'blood')]
PMC4896250	4/2016	S9475-PMC4896250	['when ba was divided into 4 groups: Neutrophil dominant (70% or more), Eosinophil dominant (3% or more), co-dominant and pauci-Granulocytic group.']	N/A	N/A	[('CL_0000775', 'neutrophil', 35, 'Neutrophil'), ('CL_0000771', 'eosinophil', 70, 'eosinophil'), ('CL_0000099', 'interneuron', 126, 'granulocytic')]
PMC4896250	4/2016	S9532-PMC4896250	['Eosinophilia %, Ige levels and native Thiol (sh), total Thiol, Disulfide (ss) ss / sh, ss / total sh, sh / total sh values were measured by the method described by erel & neseliogl (1).']	N/A	N/A	[('CL_0000771', 'eosinophil', 0, 'Eosinophilia'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 16, 'IgE'), ('CHEBI_29917', 'thiol group', 38, 'thiol'), ('CHEBI_29917', 'thiol group', 56, 'thiol'), ('CHEBI_29374', 'ditritium oxide', 63, 'disulfide')]
PMC5013256	9/2016	S16-PMC5013256	['the Primary Hematologic Cell types that generate 17S-hdha are Eosinophils (high Expression) (miyata et al., 2013) Monocytes (low Expression and high Expression in Macrophages) and Polymorphonuclear Leukocytes (low Expression but inducible during resolution) (serhan, 2014).']	N/A	N/A	[('CL_0000001', 'primary cultured cell', 4, 'primary'), ('CL_0000988', 'hematopoietic cell', 12, 'hematologic cell'), ('CHEBI_38975', 'methylbenzene', 49, '17S'), ('CL_0000771', 'eosinophil', 62, 'eosinophils'), ('GO_0010467', 'gene expression', 80, 'expression'), ('CL_0000576', 'monocyte', 114, 'monocytes'), ('GO_0010467', 'gene expression', 129, 'expression'), ('GO_0010467', 'gene expression', 149, 'expression'), ('CL_0000235', 'macrophage', 163, 'macrophages'), ('CL_0000094', 'granulocyte', 180, 'polymorphonuclear leukocytes'), ('GO_0010467', 'gene expression', 214, 'expression')]
PMC5350159	3/2017	S118-PMC5350159	['differential cell counts did not reveal a difference in Eosinophil populations among diet cohorts.']	N/A	N/A	[('CL_0000771', 'eosinophil', 56, 'eosinophil')]
PMC5350159	3/2017	S208-PMC5350159	['Allergen sensitization induces ahr and Lung inflammation resulting in Airway hyperplasia and Eosinophilia (boyce and austen2005).']	N/A	N/A	[('CHEBI_59132', 'antigen', 0, 'Allergen'), ('UBERON_0002048', 'lung', 39, 'lung'), ('UBERON_0001005', 'respiratory airway', 70, 'airway'), ('CL_0000771', 'eosinophil', 93, 'eosinophilia')]
PMC5523023	7/2017	S26-PMC5523023	['the endogenous sources of Ros are Cell Organelles (Mitochondria, Peroxisomes, Endoplasmic Reticulum), various enzymes and enzymatic Complexes (e.g., Cytochrome P450, nadph oxidases, Nitric Oxide synthase, Xanthine oxidase), Immune and non-Immune Cells (especially Phagocytes, Activated Eosinophils and Neutrophils, Monocytes and Macrophages, Airway Epithelial and Smooth Muscle Cells, Endothelium), and others (e.g., Heme proteins, reactions of metal Ions).']	N/A	N/A	[('CHEBI_8756', 'RNA (poly(A))', 26, 'ROS'), ('GO_0009986', 'cell surface', 34, 'cell organelles'), ('GO_0005739', 'mitochondrion', 51, 'mitochondria'), ('GO_0005777', 'peroxisome', 65, 'peroxisomes'), ('GO_0005783', 'endoplasmic reticulum', 78, 'endoplasmic reticulum'), ('GO_0032991', 'protein-containing complex', 132, 'complexes'), ('CHEBI_4056', 'cytochrome', 149, 'cytochrome'), ('PR_000006100', 'aromatase', 149, 'cytochrome P450'), ('CHEBI_16480', 'nitric oxide', 182, 'nitric oxide'), ('CHEBI_17957', '5-(2-hydroxyethyl)-4-methylthiazole', 205, 'xanthine'), ('CL_0000738', 'leukocyte', 224, 'immune ... immune cells'), ('UBERON_0002405', 'immune system', 224, 'immune'), ('UBERON_0002405', 'immune system', 239, 'immune'), ('CL_0000234', 'phagocyte', 264, 'phagocytes'), ('CL_0002627', 'mature astrocyte', 276, 'activated'), ('CL_0000771', 'eosinophil', 286, 'eosinophils'), ('CL_0000775', 'neutrophil', 302, 'neutrophils'), ('CL_0000576', 'monocyte', 315, 'monocytes'), ('CL_0000235', 'macrophage', 329, 'macrophages'), ('UBERON_0003209', 'blood nerve barrier', 342, 'airway epithelial'), ('CL_0000066', 'epithelial cell', 349, 'epithelial'), ('CL_0000192', 'smooth muscle cell', 364, 'smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 364, 'smooth muscle'), ('UBERON_0001986', 'endothelium', 385, 'endothelium'), ('CHEBI_30413', 'heme', 417, 'heme'), ('CHEBI_24870', 'ion', 451, 'ions')]
PMC5579643	8/2017	S48-PMC5579643	['Zinc\nchildren with Food hypersensitivity have increased amounts of Mastocytes, Eosinophils and Neutrophils in the Digestive Tract.']	N/A	N/A	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 0, 'Zinc'), ('CHEBI_33290', 'food', 19, 'food'), ('CL_0000127', 'astrocyte', 67, 'mastocytes'), ('CL_0000771', 'eosinophil', 79, 'eosinophils'), ('CL_0000775', 'neutrophil', 95, 'neutrophils'), ('UBERON_0001555', 'digestive tract', 114, 'digestive tract')]
